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II. THESIS ABSTRACT  
Background:  
A South African report, Saving Babies 2010-2011, reports 32,178 still births in 
a 2 year period of January 2010 to December 2011 within the 94% of the total 
hospitals who provide data to a Perinatal Problem Identification programme 
(PPIP). In order to deal with perinatal mortality, specifically Intra-Uterine 
Growth there is needed to equip the primary health care (PHC) with 
technology for monitoring. An instrument called the Umbiflow Doppler 
ultrasound machine has been developed and there is need to test its economic 
impact in the PHC. 
 
Methods:  
A cross- sectional analytical study was conducted in the Tygerberg Eastern 
Health District of the Metro Region of Western Cape, South Africa at two 
primary health care (PHC) facilities, one secondary level hospital, and one 
tertiary hospital namely Kraaifontein Community Health Centre (CHC), 
Durbanville Day Clinic, Karl Bremmer District Hospital, and Tygerberg 
Hospital respectively.  
 
The aim of the research was to conduct a cost analysis in the introduction of 
an Umbiflow Doppler machine in the primary health care with the major goal 
being to reduce the number of perinatal deaths in the public health system.   
 
A societal perspective was adopted. The cost analysis study was carried out on 
the already approved sample size of 139 patients stemming from the 
Umbiflow Clinical study. The inclusion criteria for patient participation was 
poor SF growth and late bookers >28 weeks attending Kraaifontein 
Community Health Care Centre and Durbanville Clinic for antenatal services.  
 
The data collection instruments comprised of two questionnaires. The first 
questionnaire was for patient costing and the second for facility costing. 
Physical observation was used to calculate the staff time per general patient 
(one who does not need a Doppler) at the primary health level. The extra staff 
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time for a Doppler needing patient was attained from the Umbiflow system 
which captures time stamps automatically and uploads the information to a 
central server. The average time needed for a Doppler was validated in the 
facility questionnaire.  
 
Results:  
The average cost was higher for secondary hospital visit for Doppler screening 
(R194.77) compared to R73.62 for a visit to the primary health care. From the 
health system perspective, the cost was 722.28 rands and 6709.78 rands in 
the primary health care setting and hospital respectively. Doppler screening 
strategy in hospital level proved less costly than clinic based Doppler strategy,  
 
Having adjusted for inflation and annualised and discounted the costs at the 
3%, the average unit cost per patient at the PHC level was estimated to be ZAR 
49.62, at the secondary level ZAR 36.27 and at the tertiary level ZAR 18.26.  
 
The low unit cost estimates at the secondary and tertiary institutions were 
mostly affected by the extremely high number of referral patients attended to 
at Tygerberg in comparison to Karl Bremmer and Kraaifontein/Durbanville 
PHCs i.e. economies of scale. However, the total costs are extremely higher at 
secondary and tertiary hospitals 
 
From the health care provider perspective only, then the hospital Doppler 
intervention is less costtly, highlighting the impact social costs have on an 
economic evaluation.  
 
Conclusions:  
The study findings show how less costly it is to adopt the portable, easy-to 
use, Umbiflow Doppler ultra-sound machine to reduce patient and health 
provider costs. It would also ensure patients do not abscond from referrals 
due to financial costs. Adopting a policy that can see wider implementation of 
the Umbiflow would be the first step to reducing the high rate of perinatal 
deaths and ensure favourable fetal outcomes.    
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1. RESEARCH PROTOCOL 
1.0 Introduction 
The study focus was on introduction of technologies that help in diagnosing 
fetus intrauterine growth retardation (IUGR) due to placental insufficiency i.e. 
the placenta’s inability to provide sufficient blood flow for the fetus to continue 
growing relative to the standard growth curve which may result in death of the 
fetus if no treatment measures are taken i.e. perinatal mortality (Calhoun Rice, 
2012). Perinatal mortality (PNMR) accounts for deaths during the period before 
the child is born (Stillbirths) and the first week of birth. It is calculated as the 
number of perinatal deaths per 1000 total births. (World Health Organisation, 
2013) South Africa’s definition of perinatal mortality differed from that of World 
Health organisation before 2005.  
 
Improvement of maternal health and reduction of child mortality form Goal 4 
and 5 of the Millennium Development Goals (MDGs) advocated by signatories to 
the United Nations in 2000, South Africa included (World Health Organisation, 
2014). To achieve these goals it is critical that the mother and the fetus obtain 
medical monitoring during the 40-42 weeks pregnancy period to avoid 
disability or death of the child or the mother.  
 
In South Africa perinatal period began at 28 weeks Gestational age at 1000g to 
day 28 days after delivery. World Health Organisation (WHO) perinatal period 
began at 22 (154 days) weeks Gestational age to day 7 (World Health 
Organisation, 2013). However, South Africa’s PNMR since 2005 has adapted the 
WHO definition of PNMR (Health Systems Trust, 2013). At what cost will the 
introduction of the technology will the perinatal deaths avoided, and if so what 
magnitude of the perinatal deaths could be avoided is an important area of 
assessment in the study.  
 
It is during this period that a fetus may fail to develop or suffers slow growth as 
a result of several clinical factors and maternal lifestyle habits (Mook-Kanamori 
et al., 2010). In case of death occurring during that period, it is recorded with 
the hope that answers as to the cause may be obtained. A South African report, 
Saving Babies 2010-2011 (Pattinson, 2013), reports 32,178 still births in a 2 
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year period of January 2010 to December 2011 within the 94% of the total 
hospitals who provide data to a Perinatal Problem Identification programme 
(PPIP)(Chopra et al., 2009).  
The PPIP has been instrumental in auditing the perinatal, neonatal and maternal 
mortality in South Africa and is supported by the District Health Information 
System (DHIS) used by the department of health to collect statistics from all 
public institutions in the country (South Africa Medical Research Council, 2014). 
Apart from relying on information from the DHIS, the South African government 
has ventured on different programmes to help in improving the maternal and 
child mortality in the country.  
One such programme is the African Union led project called The Campaign on 
Accelerated Reduction of Maternal Mortality in Africa (CARMMA) meant to 
reduce maternal, new-born and child mortality in Africa (African Union, 2012). 
The key issues rally upon sharing information on how to reduce mortality 
amongst the latter, continue, and introduce best practices and increase 
resources as well as political commitment in maternal health (African Union, 
2012).  
In essence, the pillars of CARMMA build upon the six building blocks of health 
systems strengthening namely, “service delivery; health workforce; information; 
medical products, vaccines and technologies; financing; and leadership and 
governance (stewardship).”(World Health Organisation 2007) If the 32,178 still 
births in South Africa are to be reduced and the MDG goals are to be attained, 
the aforementioned pillars will need rigorous strengthening.   
Health care financing is a key component of health systems strengthening. Who 
pays for health care is a determinant that can strengthen or cripple the system. 
It affects utilisation of health care services. In South Africa, user fees were 
abolished to allow for more expecting mothers to access health care, resulting in 
a 4.6% average increase in booked deliveries (Jo Borghi, Ensor, Somanathan, 
Lissner, & Mills, 2006).  
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However, it resulted in high maternal mortality due the failure of the increase in 
patient load not matching the staff as well as the facilities available to cater for 
the patients. Proponents of Health Care strengthening advocate for increased 
financial incentives and infrastructural and technological additions and 
improvements to offset the increased patient burden which leaves the staff 
overworked and disgruntled resulting in low quality of service provision (Jo 
Borghi et al., 2006; Gilson & McIntyre, 2005; Gilson, 1997).  
 
The introduction of technology into the PHC to assist human capital is seen as 
strengthening the Technology pillar of health systems. However, technological 
innovations are not always cheap and are usually confined to the secondary and 
tertiary institutions. Less costly technology in the clinics and community health 
centres (CHC) is likely to reduce hospital admissions by 44 %, caesarean 
sections due to foetal distress by 52% and possibly avert 20% of induced labour 
(Council for Scientific and Industrial Research, 2013). 
 
There is a continuous quest for improved efficiency and equity in the health 
system, especially when an innovation is about to be introduced in a resource 
constraint setting. The costing of health services has been used to understand 
and monitor health care costs at the national level costs right down to facility 
level. Costing of health activities falls under the umbrella subject of Economic 
Evaluation. 
 
Economic evaluation is an accepted method for the appraisal of health care 
programmes. It is one of the tools available to assist in choosing efficient 
alternatives from an array of alternatives that will maximize the use of 
resources. Economic evaluation may be defined as ‘the comparative analysis of 
alternative courses of action in terms of both their costs and consequences’ 
(Drummond et al., 1987). 
 
The economic evaluation methods include Cost Minimisation Analysis, Cost-
Benefit Analysis (CBA), cost utility (CUA), Cost Effectiveness Analysis (CEA) , 
and Budget Impact Analysis(BIA)  (Haute Autorite de Sante 2012; Drummond et 




Economic Evaluation has been essential in budgeting for health care services, 
understanding the efficiencies and inefficiencies of the health care system. 
Importantly, costing of programmes helps management in deciding whether a 
programme should be implemented or cancelled given the start-up costs or 
incremental costs to the health system. The same applies for maternal health 
care costing.  
 
a) Statement of the problem 
 Worldwide, perinatal mortality is assumed to reach 3.3 million per annum, with 
6 out of 10 being stillbirths (World Health Organisation 2006). The developing 
countries account for 90% of worldwide PNMR statistics (World Health 
Organisation, 2006).  The sub-Saharan African region has a perinatal mortality 
rate of 56 per 1,000 births (Chinkhumba et al., 2007). 
 
According to statistics from WHO, South Africa has a maternal mortality ratio of 
310 deaths per 100 000 lives births. The infant (under-1) mortality rate in 2010 
was 41 deaths per 1 000 live births, while the under-5 mortality rate was 57 per 
1 000 live births (South Africa Info. 2013). Such statistics have compelled 
national departments of health to require that all expecting mothers be 
monitored during the 9 month period, the full duration of conception to child 
birth. 
 
 In 2008/09 the National average PNMR 31.4/1000, with the Western Cape 
Province having the lowest (26.3/1000) and Free State the highest of 37.9/1000 
(Health Systems Trust, 2008). In 2011, South Africa was reported to have 61 
stillbirths per day and was ranked 176 out of 193 in terms of stillbirths (Times 
Live-SAPA, 2011). Factors attributing to perinatal death include intrauterine 
growth restriction, infections, and birth trauma, maternal disease, antepartum 
haemorrhage, intrapartum hypoxia, and spontaneous pre-term labour, fetal 
abnormalities whilst 38% of the still births are unexplainable (Health Systems 




Maternal disease may include HIV AIDs, Tuberculosis and effects from smoking 
amongst others (Health Systems Trust, 2011). Socio-economic factors also add 
to poor perinatal outcomes, e.g. poor maternal education, poor fed mothers may 
lead to low birth weight of the fetus or child (Ezechi & David 2010).  
 
Conclusions regarding quality and availability of antenatal (during pregnancy) 
and intrapartum (during labour) care can be deduced from the stats above. In 
comparison to the developed countries, these statistics paint a gory picture of 
maternal health care in South Africa.  
 
In order to avert unnecessary maternal and child mortality, South African 
government has had to concentrate on strengthening the health system pillars 
and shifting resources to primary health care (PHC) which is the first port of call 
for any pregnant woman. The National Strategic Plan for Maternal, New-born, 
Child and Women’s Health (MNCWH) and Nutrition in South Africa 2012 – 2016 
feeds into the PHC reengineering reinforcing the provision of community based 
MNCWH (South Africa’s Department of Health, 2012).   
 
Primary health care institutions are usually under resourced and face financial 
and technical problems. As part of the monitoring intrauterine growth of a fetus, 
measurements of the symphysis fundal  (SF) are done by tape measure and 
plotted against a fetal growth chart (National Collaborating Centre for Women’s 
and Children’s Health, 2008). If the fetus has small gestational age (SGA), 
precautionary measures to avoid death or disability to the fetus may be taken in 
form of different treatment regimens depending on the cause(RC Pattinson, 
2007).  
 
Due to technological innovations, the ultrasound machines have been used to 
check for low symphysis fundal. However, in developing countries where the 3D 
ultrasound machines are mostly found in the secondary level hospitals and not 
in the clinics, monitoring is restricted to tape measurements of the SF by the 
nurses. Consequently, issues of misdiagnosis of IUGR and SGA are rife and are 
only confirmed at the secondary level institutions. If a false positive occurs, 
there patient would have had to incur extra transport, time costs and lost 
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incomes whilst attending the referral which would later prove to be false. 
Secondly, the health system at secondary level incurs extra costs in evaluating 
the patient who in actual fact has no low SF as noted initially at the lower level 
hospital through tape measure usage (Dowie 2008). 
 
 
i) South Africa’s maternal health care protocol  
In South Africa, the protocol to follow when a woman tests positive for 
pregnancy, assuming the baby is wanted is noted in the Basic Antenatal Care 
handbook. It states that a woman’s ANC should begin during the first visit to the 
hospital (Pattinson, 2007). This may be in order to confirm pregnancy or when 
one already knows they are pregnant and are seeking ANC. Below is a table that 
shows the steps to be taken when a pregnancy is to be carried to full term.  
Figure 1: Steps to be followed at first visit to the clinic 
  
Source: Pattison (2007) 
 
From there onwards the fetus growth is monitored by using a tape measure to 
measure the SF (Pattinson, 2007). In the South African Health system the SF 
growth measurement is administered by the nurses in the public hospital 
setting whilst in the private sector, the gynaecologist has the responsibility 
(Cronjé, Bam, & Muir, 1993b).  In most cases the ultrasound is used as a 
secondary option to validate the results of tape measure monitoring.  
 
The high powered ultrasound machines are normally situated at higher level 
hospital facilities, not at lower level primary care such as community health 
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centres and clinics. It therefore means when a patient is found to be at risk of 
low SF, they are referred to the higher level hospital for a Doppler ultrasound, 
which is conducted by a trained sonographer on a high powered ultrasound 
machine (Pattinson, 2007). The Doppler evaluation may confirm the low SF or 
may prove that there is no low SF growth.  
 
Due to the complicated nature of evaluating fetal growth, there have been 
instances of false diagnosis noted as 2.5 times for every correct diagnosis 
(Cnattingius, Axelsson, & Lindmark, 1985) whilst some have noted 5% false 
negatives (National Collaborating Centre for Women’s and Children’s Health, 
2008).   
 
In the case of a referred patient being found to normal or not risky SF the 
patient is referred back to the community health centre or clinic for continuous 
monitoring for the rest of the pregnancy duration (Pattinson, 2007). It is 
essential to determine the costs incurred by the patients and the health care 
system in relation to the referral process to allow for reprioritisation of service 
provision which allows for efficiency and cost minimisation.  
 
b) Theoretical and empirical literature 
Several studies have been conducted to assess the effectiveness of intrauterine 
growth retardation monitoring with regards to finding clinical solutions in 
order to reduce perinatal mortality or morbidity (Henderson & Martin, 2000). 
Most of the studies compare the different strategies of monitoring IUGR and SGA 
against no monitoring at all.  
 
The study samples include women with high risk pregnancies stemming from 
previous still births, hypertension, diabetes and those who would have been 
noted to have IUGR. However, most studies concentrate on the second trimester 
more than the first, limiting the range of assessing effectiveness of monitoring 
from early on in the pregnancy. 
 
 The monitoring strategies in most of the studies include monitoring of Body 
Mass index (Haws et al., 2009), SF measurement by tape measure and Doppler 
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ultrasound (Henderson & Martin, 2000; Marsál, 1994; Stampalija, Gml, & 
Alfirevic, 2010). Ultrasound screening is considered to provide more 
information regarding SGA and IUGR than the BMI and tape measure strategies 
allowing for much more accurate diagnosis (Henderson & Martin, 2000).  
 
Some studies note there are a value in monitoring high risk pregnancies 
especially those with suspected placental dysfunction using the Doppler 
ultrasound (Haws et al., 2009; Henderson & Martin, 2000; Marsál, 1994).   
 
However, a Cochrane review of Randomised and quasi-randomised controlled 
trials of Doppler ultrasound versus no Doppler ultrasound revealed that there 
was no evidence of the mother or fetus benefiting whether the Doppler was 
performed or not on second trimester women in two of the studies reviewed. 
They however, recommended that more reviews be done on first trimester 
women (Stampalija et al., 2010) as they could be a potentially opposite result.  
 
Consequently, 16 studies reviewed collectively suggest that perinatal mortality 
can be reduced by 29% [RR 0.71, 95% CI 0.52-0.98] if Doppler monitoring is 
used together with other appropriate interventions. Despite the result, the data 
was not statistically significant. Below is a section on the history of Doppler 
ultrasound monitoring.  
 
i) Fetus intrauterine growth retardation (IUGR) monitoring with 
Ultrasound 
Amongst the technology that has been used to help human capital assess the 
health status of a fetus is the Doppler ultrasound machine. Over centuries, 
medical companies such as General Electric, Toshiba amongst others have 
competed in the production of new technologies that would, “protect fragile 
lives and promote growth and development (G.E. Healthcare, 2014).  
 
To fulfil the goal of giving peace of mind to the parents, the ultrasound including 
Doppler machines have evolved from 2D imagin,3D and now 4D imaging and is 
expected to evolve over time. The Doppler is a machine that uses sound waves 
to measure blood flow in the blood vessels. It is used to evaluate different 
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medical conditions such as strokes, pulmonary embolism, and deep vein 
thrombosis amongst others. In the case of pregnant women, it is used to check 
the blood flow through the umbilical cord to the placenta, of which supplies 
nutrients to the fetus. This is referred to as the Doppler ultrasound. A knob 
called a transducer is placed on the stomach above the blood vessels and it, 
“sends, and receives sounds that are amplified through a microphone. 
 
 The sound waves bounce off solid objects, including blood cells. The movement 
of blood cells causes a change in pitch of the reflected sound waves (called the 
Doppler Effect). If there is no blood flow, the pitch does not change. Information 
from the reflected sound waves can be processed by a computer to provide 
graphs or pictures that represent the flow of blood through the blood vessels.” 
(WebMD, 2014) 
 
The family of Doppler machines comprises of four types namely the "Bedside" 
or continuous wave, Duplex, Colour, and Power Doppler’s. All the Doppler’s 
produce sound waves which provide information on the blood flow. However 
the unlike the duplex, colour and power Doppler the continuous wave Doppler 
is portable and does not produce a picture and relies on the doctor/nurse’s 
listening skills.  
 
The Duplex Doppler produces a picture and the sound is reflect on a graph whist 
the Colour Doppler produces a picture as well as, “sounds into colours that are 
overlaid on the image of the blood vessel and that represent the speed and 
direction of blood flow through the vessel”. (WebMD, 2014) Power Doppler is 
the most sophisticated of them all and it is used in the evaluation of vessels 
found in more solid organs. The Duplex, Colour and Power Doppler machines 
are mostly found in the secondary institutions in South Africa. An example of the 
continuous wave Doppler is an Umbiflow Doppler. It is discussed in detail in the 
next section. 
 
ii) The Umbiflow Doppler Machine 
The Council for Scientific and Industrial Research (CSIR) commissioned project 
has been instrumental in the testing of a miniature ultrasound Doppler machine 
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developed by Jeremy Wallis, South African Medical Research Council, CSIR and 
funded by the South African National Research Foundation for use in the lower 
level facilities (Council for Scientific and Industrial Research, 2003). The 
Umbiflow Doppler machine is meant for patients who do not present as high 
risk at the initial visits but with further monitoring are then suspected to have 
IUGR (Council for Scientific and Industrial Research, 2003). It is similar to the 
ultrasound machines used at tertiary hospitals but does not contain imagery of 
the womb. It is in the family of the continuous wave Doppler and, “uses 
continuous-waveform ultrasound to detect the blood flow within the umbilical 
cord of a fetus.  
 
By using the Doppler Effect, the velocity of the blood flow can be determined, 
and from this an assessment is made on the ability of the placenta to supply 
sufficient oxygen and nutrition to the growing fetus.”(Council for Scientific and 
Industrial Research, 2013) The Umbiflow Doppler which is used in conjunction 
with a computer and does not need a trained and experienced sonographer and 
can be operated by trained midwives and nurses.  
 
A similar Pentium 3 PC based Umbiflow Doppler was used at Tygerberg hospital 
in the Western Cape Province (South Africa) for at least 5 years and placed in 2 
community health care centres for trial purposes between the years 2002 and 
2004  (Hugo, Grove, & Odendaal, 2007) as part of the primary health care 
reengineering programme.  
 
The description of how the Umbiflow works by the manufactures is noted as 
follows,   
“Umbiflow consists of a self-contained software programme and a vascular 
transducer in the form of a hand-held probe that plugs into the USB port of a 
computer (desktop, notebook, or tablet). The USB port provides power to the 
probe and facilitates the signal transfer to a software application. The software 
processes the Doppler ultrasound signals to generate a high quality waveform 
depiction of the umbilical blood flow, and automatically calculates the so-called 
“resistance index” (RI) which can be directly linked to the functioning of the 
placenta. The blood flow umbilical cord is also audible in the loudspeakers and a 
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digital interface allows the user to print the test results. Umbiflow is connected via 
the mobile network, and allows for remote expert monitoring so that centrally 
located obstetricians.”(Council for Scientific and Industrial Research, 2003) 
 
The study revealed the Umbiflow Doppler test run on the Pentium 3 PC which 
produced a normal flow velocity waveform was less likely to be followed by 
perinatal deaths (Hugo et al., 2007). However, no full economic impact study 
was done i.e. of the health system and from the patient perspective. 
 
Figure 2: The Umbiflow ultrasound Doppler machine 
  
Source: Council for Scientific and Industrial Research 2013 
 
iii) Costing Models  
The costing of health services has been used to understand and monitor health 
care costs at the national level costs right down to facility level. Costing of health 
activities falls under the umbrella subject of Economic evaluation. The subject 
sub-categorises economic evaluation into cost minimisation, cost utility, cost 
effectiveness, cost benefit and cost analysis (Drummond, Sculpher, & Hons, 
2005; Haute Autorite de Sante, 2012; Torrance & Stoddart, n.d.). This has been 
essential in budgeting for health care services, understanding the efficiencies 
and inefficiencies of the health care system.  
 
Importantly, costing of programmes helps management in deciding whether a 
programme should be implemented or cancelled given the start-up costs or 
incremental costs to the health system. The same applies for maternal health 
care costing. There is an urgency to save funds whilst continuing to provide 
quality maternal health care, thus the need to find out at what cost the 
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programme can be implemented and the incremental costs of adding a service 
in a facility. The cost effectiveness studies around the issue of stepping up 
maternal health care are mostly concentrated in developing countries where 
98% of the worldwide perinatal deaths occur (Bhutta, Yakoob, Lawn & Rizvi, 
2011).  
 
A study of maternal health care costs in 3 countries namely Malawi, Uganda and 
Ghana assessed the different facility costs to help ascertain any need for 
management restructuring for improvement of maternal health services (Levin 
et al., 2003). The costing study of maternal health care in Blantyre district, 
Malawi revealed the complexities of different facility arrangements. The costs at 
public hospitals were noted to be higher than those at mission hospitals, an 
inverse to most studies which found mission hospitals to be less costly. Like 
South Africa, Ghana offers free ANC. In a cross sectional study which followed a 
step-down allocation approach, the average cost per ANC visit in Ghana from the 
health care perspective was US$18 (Dalaba et al., 2013).  
 
In the case of facilities offering intense basic and advanced care to pregnant 
women, with a 99% coverage approximation, there is likelihood that 45% of 3 
million still births in the 3rd trimester recorded annually worldwide (Robert 
Pattinson, Kerber, Buchmann, & Friberg, 2011), 54% of maternal deaths (Bhutta 
et al., 2011), and 43% of the Neonatal deaths could be deterred in 68 priority 
countries of which South Africa is included (Robert Pattinson et al., 2011).  
 
The cost as deduced from the Lives Saved Tool for the preferred outcome would 
amount to between $0.96 $US 2,32 per pregnant woman monitored using 
ingredients costing of recurrent costs only, i.e. not capital costs included. A 
primary costing conducted at Liverpool Women’s Hospital regarding 
ultrasounds on pregnant women revealed a cost of ultrasound for growth 
abnormalities to be approximately £15.71 (£13.58–£17.84) whilst for fetal well-
being scan cost £15.46 (£11.67–£21.16) (Henderson & Martin, 2000).  
 
A review of Popline, Medline and donor websites databases reviewed that they 
were not many cost effectiveness, cost utility, cost benefit and cost analysis in 
19 
 
the field of maternal health (Josephine Borghi, n.d.). A few that could be found 
are listed in Table 1.  
 
Table 1: Studies on Cost of Antenatal Care (US$) 
ē  
 Source: Borghi (n.d.) 
The cost for South Africa listed in the table above was for the year 2000 
(Jinabhai et al., 2000) and there don’t seem to be any studies accessible on the 
public domain going forth.   
 
1.1 Rationale of the Study  
Given the discussion above, it is imperative that a study be carried out that 
sheds more light on the introduction of low cost technology which is also 
clinically effective in monitoring pregnancies and reduce unwarranted referrals 
to secondary and tertiary level of care hospitals.  The purpose of the study is 
therefore to present a cost analysis of introducing the technology. 
 
The Umbiflow Doppler wave machine discussed in the literature review is one 
such machine and considering a randomised control study (Cnattingius et al. 
1985; Council for Scientific and Industrial Research, 2013; Cronjé, Bam, & Muir, 
1993a; Haute Autorite de Sante, 2012) on it has proven it clinically effective, the 
economic impact needs to be proven and well documented before the decision 
to introduce the machinery in the primary health care level is taken.  
 
The system can be manufactured at low cost and is easy-to-use so that only little 
training is required in order to obtain a Doppler measurement. The Umbiflow 
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software has since been upgraded and is being used in conjunction with a 
notebook (laptop) making it much more user friendly. Consequently, Umbiflow 
was specifically designed for use by nursing staff and midwives at primary 
health care facilities and antenatal clinics in remote settings where patients face 
long distances to a referral facility (Council for Scientific and Industrial 
Research, 2003).  
 
One of the benefits of Umbiflow is that reduces “costs associated with secondary 
level tests that require specialised medical staff involvement” (Council for 
Scientific and Industrial Research, 2003). Estimates for standalone ultrasound 
equipment have been pegged at ZAR 200,000 with high-end equipment costing 
approximately ZAR 1.5 million (Council for Scientific and Industrial Research, 
2013), too expensive to allow for the same specialised equipment to be placed 
at primary health care level.  
 
The Umbiflow is produced at much lower costs (Council for Scientific and 
Industrial Research, 2013). It is essential to determine the true economic impact 
from the health and the social perspective if Umbiflow Doppler machine is to be 
permanently introduced in the primary health care level in South Africa’s’ public 
healthcare system.  
 
1.2 Study Purpose and Objectives  
The study purpose is to determine the economic impact of introducing an 
Umbiflow Doppler machine at the primary care level. The Objectives of the 
study are as follows: 
• To determine the cost of introducing a continuous-wave Doppler analyser 
(Umbiflow Intervention) at primary antenatal care facilities 
• To determine the average cost per patient to the secondary level hospital 
from the patient’s perspective 
• To determine the average cost per patient referral for a Doppler to the 
secondary level hospital from the health system perspective 
 
1.3 Methods  




 Umbiflow intervention programme 
The study is cross- sectional analytical study. A societal perspective was  taken 
in order to include not only the cost to the health sector but also the patient 
(Drummond et al., 2005; Guide, 2012; Tan-torres, 1981; Torrance & Stoddart, 
n.d.). It is more beneficial to include the patient perspective which gives a broad 
view on society’s welfare which helps in policy decision making (Byford & 
Raftery, 1998).  
 
The Economic Impact study was  carried out on the already approved sample 
size of 139 patients stemming from the Clinical study. The 139 patient stems 
from the sample size calculation by Dr. Justin Harvey at Stellenbosch University. 
The inclusion criteria for patient participation is poor SF growth and late 
bookers >28 weeks attending Kraaifontein Community Health Care Centre and 
Durbanville Clinic for antenatal services. Based on that statistically established 
that 139 patients will fulfil the ethics approved inclusion criteria.  
 
1.4 Measurements 
a)     Instruments  
The data collection instruments comprised of two questionnaires. The first 
questionnaire was for patient costing and the second for facility costing. The 
first section captured demographic information, followed by socio-economic 
information, patient direct and indirect costs, and lastly guardian costs. The 
interviewer relied more on recall by the patient on their expenditure.  
 
The facility costing relied on interviews of the staff at the different level facilities 
using a standard questionnaire. The first section of the facility costs 
questionnaire captures the general facility information such as name of facility, 
level of facility, opening times etc. This is followed by staff time for Doppler 
administering, equipment and furniture, building, and training costs.  
 
Physical observation was used to calculate the staff time per general patient 
(one who does not need a Doppler) at the primary health level. The extra staff 
time for a Doppler needing patient will be attained from the Umbiflow system 
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which captures time stamps automatically and uploads the information to a 
central server. The average time needed for a Doppler was validated in the 
facility questionnaire.  
 
1.5 Analysis Plan  
a) Data Management 
The hard copies of questionnaires are stored in a locked compartment and will 
be kept for the next 2 years after completion in which case they will be 
destroyed. Access to the questionnaires is limited to the researcher, supervisor, 
and the clinical research team put together by mHealth Inc.  
 
b) Data Analysis 
A societal perspective was adopted in the cost analysis. The costs were divided 
into 2 categories namely health systems and patient costs. The costs were 
calculated in Rand value, the South African currency at the year 2013 prices. 
Data was entered and summarised in the Microsoft excel for health care 
facilities. Microsoft excel was  used to analyse the data. The Doppler ultrasound 
administering to a patient at different levels of care was  be costed.   
 
Health Systems Costs 
The costs assessed encompassed the referral to secondary and tertiary 
institutions as well as implementing Umbiflow at primary health care level. The 
direct health system costs included recurrent costs of administering a Doppler 
were  included in the analysis and where costs are shared, proportional 
allocation was used for calculations . These include consumables during patient 
assessment and staff costs. Overhead costs for Tygerberg and Karl Bremmer 
Hospitals, were not - included since they are an inherent part of the hospital 
programme and did not change due to the implementation of a Doppler 
programme.  
 
The same applied to the clinics though it was  clear the electricity bill for the 
clinic was affected assuming full implementation of the Doppler wave 
ultrasound or the 3D ultrasound at clinic level. Therefore, the electricity 
overhead costs were included in the primary health care level facility costing as 
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noted by Drummond, during a societal perspective costing, it is important to be 
weary of some costs causing measurement challenges when they do not have a 
major impact on the study results (Drummond et al., 2005).  
 
Training costs for the staff administering were included. Training was 
considered a future investment and was discounted with 5%, 3% and 0% for 
comparison purposes. Capital costs were annualised to ascertain the cost in the 
year of assessment given they were used over a longer period of time.  
 
The rate at which to discount cost has always controversial but there is a 
general consensus amongst economic evaluators. The French use the a social 
discount rate of at 4% as of 2005, assuming the time horizon is less than 30 
years, reducing up to 2% thereafter (Haute Autorite de Sante, 2012). In a review 
of 147 economic evaluation studies conducted by the University of York the 
most commonly used rates for health costs were 3% and 5%, whilst some 
studies used 0% (Smith & Gravelle, n.d.).  
 
Using the 3%-5% annual rate since it has been used in most of the published 
material gave room for referencing and comparison (Drummond 2005). The 
costs were discounted at 3% annually. Sensitivity analysis was done on the 
discount rate using 0% and 5%.  
Costs of referral to the regional hospital (Karl Bremmer Hospital) or tertiary 










                 PV = the present value; t = the period in which the costs 
occur; r i=the discount rate.  
 
Patient Costs 
The patient direct costs  calculated included transport costs, food costs, and any 
payment for child care during the referral visit. Indirect costs  included, 
opportunity cost of the referral, lost productivity which could be measured in 
terms of wages lost. This followed  the economic evaluation method of the 
human capital and the friction costs method (Haute Autorite de Sante, 2012). 
Human capital entailed  giving value to potential productivity loss whilst the 
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friction costs method calculated the loss of production due to absence at work 
(Haute Autorite de Sante, 2012).   
 
Below is a table showing the cost parameters that were  included in analysis.  
 
 
Table 2:  Categories of Cost Parameters  
 
 Outcomes expected included the 
• Average cost per patient /referral  
• Average Health system cost per patient/referral  
• Costs for introduction of Umbiflow Doppler Wave ultrasound in the 
primary health level  
• Cost of introducing a 3D Doppler ultrasound machine in the primary 
health sector 
 
1.6 Ethics  
1. Research Study proposal approval 
This proposal was  submitted to the Human Research Ethics committee at the 
University of Cape Town. It should be noted that the clinical and economic 
impact research protocol of the Umbiflow Blood Flow Velocity Doppler System 
has been submitted to the CSIR and Stellenbosch for approval and was accepted. 
It was then forwarded to the Western Cape Department of health and was also 
Cost Category Type of cost Components Description 
Recurrent costs
Consumables wipes, gel




Equipment knob, beds, chairs, ultrasound , computer
Training facilitator, writing materials, training materials 
Building 
Transport public taxi , public taxi or bus, private car 
Food
Child care creche 
Gaurdian 






approved. The approvals have been added in the appendix section. The study 
adhered  to the Declaration of Helsinki principles.  
 
Informed consent 
A Standard English consent form was developed for the clinical study and the 
same participants were interviewed for the economic impact assessment of the 
Umbiflow study. Consent was obtained from the patients using the standard 
form which has also been translated into Xhosa and Afrikaans. The participants 
voluntarily participated in the study and are allowed to withdrawal from 
participating at any point in time without explaining why. The participants were 
made aware of the reason of the economic impact research and the implications 
to the health system as well as to themselves.  
2. Participant confidentiality  
In order to protect the participants, special identifiers in form of unique 
numbers were  used for each participant on the questionnaire. Only the 
research team had  access to information on the questionnaires or any other 
information relating to the patients. Contact with the patients was only 
restricted to the research team.  
3. Risks and Benefits of participation 
Participation in the economic impact assessment has no risk whatsoever. It did  
no bodily harm to the participant or their pregnancy. The possible benefit 
derived from the study was  to show the extent to which time and money is 
saved for the patient in case the Umbiflow is introduced at the primary health 
care level. 
1.7 Stakeholder and Reporting  
a)   Stakeholders    
 The parties that were  affected by information provided by the study were : 
 Pregnant women 
 Council for Scientific and Industrial Research (CSIR)Provincial Health 
Department   
 Medical Research Council  
 Stellenbosch University  
 South African National and Provincial Health Departments 
 South African Health Care Facilities  
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 University of Cape Town 
 
b) Reporting  
The outcome of the study was  disseminated to the stakeholders in the form of a 
report. The findings was also be presented at a Maternal Health Conference 
2015. Participants  also received the outcomes translated into layman’s 
language in English, Afrikaans, and Xhosa in the form of a pamphlet.  
1.7 Logistics  
The duration of the research is expected to be 7 months as shown in the 















Literature Review x x x x
Review of protocol/tools x
Review of financial records (comparator 
Umbiflow) clinic level x x
Review of financial records (comparator 
duplex mode sonar) higher level care x x




Data entry and analysis patient questionnaires x x x x x
Data entry and analysis nurse/operator questionnaires x x
Data entry and analysis study nurse questionnaires x
Data entry and analysis health systems
records/researc
h x x
Final data analysis for results section x x x x
Write-up x x x x x x x x
Report x
Paper and dissemination of findings x x
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1.9 Protocol Appendices 
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Clinic 4






1.04 What type of area is the facility located in?
1.05 What year did the facility open? Example: 1941
a. Month
b. Year
07:30hrs to 16:00hrs 1
Open 24hrs a day (doesn’t close) 2
At the facility 1
Outreach 2
1.08 All of the above 3
1.09 How many times a week are antenatal sessions provided? Number
1.10 What time do the antenatal visits start and end? 
How often are outreach activities scheduled per month
Number of visits per month
If no outreach enter 999
1.12 How many zones are supported by this facility?
1.13 What is the number of pregnant women in the catchment population of the facility in 2013?
1.14 How many staff work in the antenatal clinic/ward?
How does the facility provide antenatal services?
EXAMPLE:    IF STARTS AT 7 AM, RECORD 0700                                                                      
IF IT ENDS AT 7PM, RECORD 1900
1.11 
1.06 When was the last major renovation in last 3 years?
1.07 What time does patrient care start and end?
1.01 Type of health facility







2 Staff Time for Doppler Administering
1.) In your opinion, do staff involved in the doppler  programme have any spare or non-productive time?
(Also indicate non-productive time caused by situations not controllable by the staff)
2.) Other than normal staff time, do health workers spend overtime or use their off-days to conduct doppler services?
3.) Do you engage retired nurses or other health workers on contract to conduct doppler services. 
If YES, record the number of hours and activities supported in the table below.
4.)
INTERVIEWER: List all health staff by position 
working in the facility that spend time on doppler 
administering etc. Include retired or par- time staff 
who assist in this activity 
Civil servant (SALARY SCALE) 
(PLEASE REFER TO 
PREVIOUS MONTH)
Number of years in 
position
How many days per week 
does a member of staff 
usually work at this health 
facility?
How many hours per week 
does a member of staff 
usually work at this health 
facility?
What portion of these hours 
is spent on doppler related 
activities?























3 Equipment and Furniture Brand name Capacity Number Used Useful Life
Current age of 
item

























What is the approximate area of the 
Health Centre? Sq Meters
4.01
What is the approximate area of the 




Are these rooms used exclusively for 
where the doppler is administered? Yes/No
4.01
If No, what percent of facility working time 




What is the approximate area of the 
room(s) where  the doppler machine is 
stored (if different from above)?
Sq Meters
4.01
Are these rooms used exclusively for the 
doppler storage? Yes/No
4.01
If No, what percent of facility working time 
are these rooms used for doppler 
machine storage? (In the case of storage 




What is the approximate area of the 
room(s) where doppler supplies and 




Are these rooms used exclusively for 
doppler supply storage? Yes/No
4.01
If No, what percent of facility working time 































: Provide additional inform














































































































































































































































ere any of 
these training 

















per day for 
training?
W
hat did the 
facility pay for 
organizing the 
events ? Put 







for printing and 
stationery ? Put 




as the total 
expenditure m
ade 
for training ? Put 



































Appendix F: Council for Scientific and Industrial Research (CSIR) Research 





2. LITERATURE REVIEW 
The literature review section will review theoretical and empirical literature. 
The key words used in literature search included, perinatal mortality, maternal 
mortality, Doppler ultrasound, symphysis fundal (SF), fetal growth chart and 
gestational age (SGA). The search yielded 160 publications. However, not all of 
them met the criteria required. The criteria were to include articles which 
included costing information in the area of maternal health. Most of the articles 
were limited to clinical information only without and economic information on 
introduction of technologies in the health system. A 106 articles were then used 
as part of this literature review.  
 
2.1 Introduction  
There is an urgency to save funds whilst continuing to provide quality maternal 
health care, thus the need to find out at what cost the programme can be 
implemented and the incremental costs of adding a service in a facility. The cost 
effectiveness studies around the issue of stepping up maternal health care are 
mostly concentrated in developing countries where 98% of the worldwide 
perinatal deaths occur (Bhutta et al., 2011).  
 
Improvement of maternal health and reduction of child mortality form Goal 4 
and 5 of the Millennium Development Goals (MDGs) advocated by signatories to 
the United Nations in 2000, South Africa (SA) included (World Health 
Organisation, 2014). To achieve these goals it is critical that the mother and the 
fetus obtain medical monitoring during the 40-42 weeks pregnancy period to 
avoid disability or death of the child or the mother (Patterson, 2007). It is 
during this period that a fetus may fail to develop or suffer slow growth as a 
result of several clinical factors and maternal lifestyle habits (Mook-Kanamori et 
al., 2010).  
 
A South African report, Saving Babies 2010-2011, reports 32,178 still births in a 
2 year period of January 2010 to December 2011 within the 94% of the total 
hospitals who provide data to a Perinatal Problem Identification programme 
(PPIP)(South Africa Medical Research Council, 2014). The PPIP has been 




Africa and is supported by the District Health Information system (DHIS) used 
by the department of health to collect statistics from all public institutions in the 
country (South Africa Medical Research Council, 2014).  
 
Apart from relying on information from the DHIS, the South African government 
has ventured on different programmes to help in improving the maternal and 
child mortality in the country. One such programme is the African Union led 
project called The Campaign on Accelerated Reduction of Maternal Mortality in 
Africa (CARMMA) meant to reduce maternal, new-born and child mortality in 
Africa (African Union, 2012).  
 
The key issues rally upon sharing information on how to reduce mortality 
amongst the latter, continue, and introduce best practices and increase 
resources as well as political commitment in maternal health. In essence, the 
pillars of CARMMA build upon the six pillars of health systems strengthening 
namely, “service delivery; health workforce; information; medical products, 
vaccines and technologies; financing; and leadership and governance 
(stewardship).” (World Health Organisation, 2007)  If the 32,178 still births in 
South Africa are to be reduced and the MDG goals are to be attained, the 
aforementioned pillars will need rigorous strengthening.   
 
The introduction of technology into the PHC to assist human capital is seen as 
strengthening the Technology pillar of health systems. However, technological 
innovations are not always cheap and are usually confined to the secondary and 
tertiary institutions. Less costly technology in the clinics and community health 
centres (CHC) is likely to reduce hospital admissions by 44 %, caesarean 
sections due to foetal distress by 52% and possibly avert 20% of induced labour 
(Council for Scientific and Industrial Research, 2013). 
 
2.1.1 South Africa Maternal Health 
 
Neonatal mortality background  
Worldwide, perinatal mortality is assumed to reach 3.3 million per annum, with 




countries account for 90% of worldwide PNMR statistics (World Health 
Organisation, 2006). According to statistics from WHO, South Africa has a 
maternal mortality ratio of 310 deaths per 100 000 lives births. The infant 
(under-1) mortality rate in 2010 was 41 deaths per 1 000 live births, while the 
under-5 mortality rate was 57 per 1 000 live births (South Africa Information, 
2013).  
 
National departments of health require that all expecting mothers be monitored 
during the 9 month period, the full duration of conception to child birth. In 
2008/09 the National average Perinatal Mortality Rate (PNMR) was 31.4/1000, 
with the Western Cape Province having the lowest (26.3/1000) and Free State 
the highest of 37.9/1000 (Health Systems Trust, 2008). In 2011, South Africa 
was reported to have 61 stillbirths per day and was ranked 176 out of 193 in 
terms of stillbirths (Times Live-SAPA, 2011). The table below gives a summary 
of births and deaths per level of care in South Africa during the years 2010-
2011.  
 
Table 3: South African Birth and Deaths per Level of Care 2010-2012 
 
Source: Pattison (2013) 
 
 Factors being attributing to perinatal death include intrauterine growth 
retardation, infections, and birth trauma, maternal disease, antepartum 
haemorrhage, intrapartum hypoxia, and spontaneous preterm labour, fetal 













Total births 209096 548976 350838 99257 116399 1324566
Liveborn 207400 536883 341165 95956 111409 1292813
Survivor 207067 530229 336075 93746 108414 1275531
Early Neonatal Death 305 6257 4184 1765 2378 14889
Still Birth 1696 12093 9673 3813 4990 32265
Perinatal deaths 2001 18350 13857 5578 7368 47154
Total births 207017 544480 345277 96871 112216 1305861
Liveborn 206791 534580 338236 94478 109019 1283104
Survivor 207067 529358 334816 93024 107144 1271409
Early Neonatal Death 205 4895 2747 1110 1425 10382
Still Birth 1219 9900 7041 2749 3197 24106






Trust, 2011). Maternal disease may include HIV AIDs, Tuberculosis and effects 
from smoking amongst others (Health Systems Trust, 2011). Unexplained 
deaths are the highest amongst all causes or perinatal and still births in South 
Africa for babies weighing below 1000g.  
 
Socio-economic factors also add to poor perinatal outcomes, e.g. poor maternal 
education, poor fed mothers may lead to low birth weight of the fetus or child 
(Ezechi & David, 2010). Conclusions regarding quality and availability of 
antenatal (during pregnancy) and intrapartum (during labour) care can be 
deduced from the stats above. In comparison to the developed countries, these 
statistics paint a gory picture of maternal health care in South Africa. Below is a 
table that shows how much of the perinatal, stillborn, and early neonatal deaths 
are unexplained, caused by intrauterine growth retardation (IUGR).  
 
Table 4: The primary obstetric causes of death per level of care for babies 
500g or more 
Source: Saving Babies 2010-2011 
 
In order to avert unnecessary maternal and child mortality, South African 
government has had to concentrate on strengthening the health system pillars 
and shifting resources to primary health care (PHC) which is the first port of call 
for any pregnant woman. The National Strategic Plan for Maternal, New-born, 
Child and Women’s Health (MNCWH) and Nutrition in South Africa 2012 – 2016 
feeds into the PHC reengineering reinforcing the provision of community based 













Unexplained intrauterine death 3.18 9.09 9.39 13.74 9.02
Intrauterine growth retardation 0.28 0.38 0.91 0.54 1.07
Still Births
Unexplained intrauterine death 3.17 9.05 9.36 13.51 8.99
Intrauterine growth retardation 0.25 0.3 0.78 0.4 0.93
Early neonatal deaths





As part of the monitoring intrauterine growth of a fetus, measurements of the 
symphysis fundal  (SF) are done by tape measure and plotted against a fetal 
growth chart (National Collaborating Centre for Women’s and Children’s Health, 
2008). If the fetus has small gestational age (SGA), precautionary measures to 
avoid death or disability to the fetus may be taken in form of different treatment 
regimens depending on the cause. Due to technological innovations, the 
ultrasound machines have been used to check for low symphysis fundal. 
However, in developing countries where the 3D ultrasound machines are mostly 
found in the secondary level hospitals and not in the clinics, monitoring is 
restricted to tape measurements of the SF by the nurses.  
 
Consequently, issues of misdiagnosis of IUGR and SGA are rife and are only 
confirmed at the secondary level institutions. If a false positive occurs, the 
patient would have had to incur extra transport, time costs, and lost incomes 
whilst attending the referral which would later prove to be false. Secondly, the 
health system at secondary level incurs extra costs in evaluating the patient who 
in actual fact has no low SF as noted initially at the lower level hospital through 
tape measure usage.  
 
2.1.2 Innovative technologies and maternal and child health   
The development of medical equipment has been central to fighting disease. The 
same applies to maternal and child health. Over the years new technologies 
have been developed to improve the outcomes of treating a patient. In Africa, 
maternal health has suffered greatly due to poor economies and non-
functioning health systems. C.M. Morel et al., (2005) notes that,   
“Improving the health of the poorest people in the developing world depends on 
the development of many varieties of health innovations, such as new drugs, 
vaccines, devices, and diagnostic tools, as well as new techniques in process 
engineering and manufacturing, management approaches, software, and policies 
in health systems and services.” (Morel et al., 2005) 
 
The screening of expectant mothers and need for prompt  identification of those 




increased referrals to higher level hospitals equipped to handle the major 
complications. One of these technological innovations to detect IUGR is the 
Doppler ultrasound machine. 
 
The Doppler ultrasound technology analyses blood flow and wave forms to 
measure blood flow in the blood vessels. It is a non-invasive measurement 
which reduces the incidence of costly invasive procedure which may prove 
unnecessary. It has been hailed for providing medical solutions through the 
mapping of blood flow in two dimensional forms and of recent years in three  
and four dimensional forms (3D and 4D imaging) which are expected to evolve 
over time (WebMD 2014). 
 
The maternal Doppler ultra-sound is an innovation from the broader 
technologies of Dopplers which has led to the discovery of new clinical 
applications  (Sigel 1998).  Because Doppler technology deals with measuring 
and sensing blood flow in the vascular system, it is used to evaluate different 
medical conditions such as strokes, pulmonary embolism, and deep vein 
thrombosis amongst others. 
 
 In the case of pregnant women, it is used to check the blood flow through the 
umbilical cord to the placenta, of which supplies nutrients to the fetus (WebMD 
2014). A knob called a transducer is placed on the stomach above the blood 
vessels and it, “sends, and receives sounds that are amplified through a 
microphone. The sound waves bounce off solid objects, including blood cells. 
The movement of blood cells causes a change in pitch of the reflected sound 
waves (called the Doppler Effect). If there is no blood flow, the pitch does not 
change. Information from the reflected sound waves can be processed by a 
computer to provide graphs or pictures that represent the flow of blood through 
the blood vessels.”(WebMD 2014) 
 
The family of Doppler machines comprises of four types namely the "Bedside" 
or continuous wave, Duplex, Colour, and Power Doppler’s. All the Doppler’s 
produce sound waves which provide information on the blood flow. However 




and does not produce blood vessel  pictures or those of surrounding organs and 
relies on the doctor/nurse’s listening skills (WebMD 2014).  
 
The Duplex Doppler produces a picture and the sound is reflect on a graph whist 
the Colour Doppler produces a picture as well as, “sounds into colours that are 
overlaid on the image of the blood vessel and that represent the speed and 
direction of blood flow through the vessel”. (WebMD 2014) Power Doppler is 
the most sophisticated of them all and it is used in the evaluation of vessels 
found in more solid organs. The Duplex, Colour, and Power Doppler machines 
are mostly found in the secondary institutions in South Africa. An example of the 
continuous wave Doppler is the Umbiflow Doppler Machine. It is discussed in 
detail in the next section. 
 
2.1.3 The Umbiflow Doppler Machine 
The Council for Scientific and Industrial Research (CSIR) commissioned project 
has been instrumental in the testing of a miniature ultrasound Doppler machine 
developed by Jeremy Wallis, South African Medical Research Council, CSIR and 
funded by the South African National Research Foundation for use in the lower 
level facilities (CSIR 2003).  
 
The Umbiflow Doppler machine is meant for patients who do not present as 
high risk at the initial visits but with further monitoring are then suspected to 
have IUGR (CSIR 2003). It is similar to the ultrasound machines used at tertiary 
hospitals but does not contain imagery of the womb. It is in the family of the 
continuous wave Doppler and, “uses continuous-waveform ultrasound to detect 
the blood flow within the umbilical cord of a fetus.  
 
By using the Doppler Effect, the velocity of the blood flow can be determined, 
and from this an assessment is made on the ability of the placenta to supply 
sufficient oxygen and nutrition to the growing fetus.”(CSIR 2013) The Umbiflow 
Doppler which is used in conjunction with a computer based does not need a 
trained and experienced sonographer and can be operated by trained midwives 





A similar Pentium 3 PC based Umbiflow Doppler was used at Tygerberg hospital 
in the Western Cape Province (South Africa) for at least 5 years and placed in 2 
community health care centres for trial purposes between the years 2002 and 
20041 (Hugo et al., 2007) as part of the primary health care reengineering 
programme.  
 
The description of how the Umbiflow works by the manufactures is noted as 
follows,   
“Umbiflow consists of a self-contained software programme and a vascular 
transducer in the form of a hand-held probe that plugs into the USB port of a 
computer (desktop, notebook, or tablet). The USB port provides power to the 
probe and facilitates the signal transfer to a software application. The software 
processes the Doppler ultrasound signals to generate a high quality waveform 
depiction of the umbilical blood flow, and automatically calculates the so-called 
“resistance index” (RI) which can be directly linked to the functioning of the 
placenta. The blood flow umbilical cord is also audible in the loudspeakers and a 
digital interface allows the user to print the test results. Umbiflow is connected via 
the mobile network, and allows for remote expert monitoring so that centrally 
located obstetricians.”(CSIR 2003) 
 
The study revealed the Umbiflow Doppler test runs on the Pentium 3 PC which 
produced a normal flow velocity waveform was less likely to be followed by 
perinatal deaths (Hugo et al. 2007). However, no full economic impact study 
was done i.e. of the health system and from the patient perspective. 
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Figure 3: The Umbiflow ultrasound Doppler machine 
 
Source: Council for Scientific and Industrial Research 2013 
 
Health care is a dominant economic and political issue in many economically 
developing and even developed nations. Most of these nations have experienced 
rapid increases in their healthcare spending over recent years. This challenge 
creates a continuing quest for reaching better health system efficiency, equity as 
well as quality and safety. It is therefore essential that all the budgeting and 
programme planning be costed beforehand. As noted by Henderson, 2002 
economic costing of ultrasound scans are very sparse.  
 
2.2 Costing  
 
Cost Effectiveness Analysis (CEA) 
Cost Effectiveness Analysis (CEA) concentrates on evaluation costs against 
outcomes/benefits when implementing a programme. The outcomes of the 
programmes should however be the same e.g. life years saved. The outcomes 
are not measured in monetary terms. Cost effectiveness studies assess different 
strategies, i.e. the current strategy and an alternative and in some cases 3 or 
more alternatives in order to find the best alternative and efficient way of 
implementation of the programme or screening in this study (Drummond 
1987).  
 
Drummond notes that CEA is measured as a ratio i.e. the Incremental Cost 





 $CostA - $CostB 
EffectA –EffectB 
 
Below is a depiction of CEA Decision Plane as noted by Drummond (1987)   
 
Figure 4: CEA Decision Plane  
 
 
Source: Drummond (1987)  
Furthermore CEA is divided in three categories, namely Ex-post, Ex-ante, and 
Intermediary evaluation (European Commision n.d.). Ex-ante evaluations are 
defined as those that support decision making through strategy choice. Ex-post 
evaluation is done once an evaluation has already been carried out and there is 
need to measure the programmes economic efficiency.  
 
Intermediary evaluations are an update of the ex-ante’s outcomes and inform 
the choice of which strategies should continue or be slatted. CEA however has 
its own limitations which include its inability to evaluate programmes with 
different outcomes (Drummond et al. 2005). Secondly, it is meant for 
programmes whose costs and outcomes are easily identifiable (European 





Thirdly, there is debate amongst economists on which costs to include and how 
they should be valued e.g. in terms of lost productivity time, care giver time and 
extended costs for life years gained due to intervention success (World Health 
Organisation 2003).  
 
Cost Minimisation Analysis 
In comparison a cost minimisation analysis determines the minimal cost to 
implement a programme assuming the available input costs only whilst 
assuming outcomes of alternative strategies to be equal Baghbanian & Esmaeili 
(2012). This is different from CEA and CUA which notes the difference in 
outcomes. The weakness is the assumptions that the outcomes/outputs are 
equal which does not reflect real life.  
 
Cost Benefit Analysis 
Like the other economic evaluations, cost benefit analysis includes monetary 
measurements but measures the outcomes differently. An example is that of 
using willingness to pay as a proxy for benefits/outcomes. This implies putting 
monetary value on pain suffering and life is usually disliked by society and 
considered unreliable due to varying ways people’s perception of their health 
weights in terms of money.   (Drummond 1987, Brown et al., 1998).   
 
Ratios are calculated when doing a cost benefit analysis and the strategy with a 
higher cost benefit or net present value or net benefit ratio is the most cost 
effective (Baghbanian & Esmaeili 2012).  
Cost Utility analysis 
 Cost Utility analysis is often used interchangeably with cost effectiveness 
analysis. However, there is a major difference in that CUA allows for different 
outcomes for comparability therefore one can analyse programmes with 
different outcomes. CUA measurement unit on outcomes include Quality 
Adjusted Life Years (QALYs) and Disability Adjusted Life Years (DALYs) which 
group the outcomes and make it possible for comparison (Baghbanian & 






CUA requires some common outcome measures that can incorporate quantity and 
quality of life changes. Such measures can be seen as measures of utility (or value of 
health) to individuals. This means strong assumptions have to be made with regards 
to methods of measuring the health related quality of life. The Euroqol is a popular 
method which had been used to date (EuroQol Research Foundation 2014). It 
consists of different weighting measurements such as the EQ-5D-5L and the EQ-5D-
3L value sets. These are currently available for the following countries: Denmark, 
France, Germany, Japan, the Netherlands, Spain, Thailand, UK, US and Zimbabwe 
(EuroQol Research Foundation 2014). Using the same valuations for different 
countries may result in inaccurate or unreliable cost utility measurements.  
 
An example is that of comparing a Tuberculosis (TB) treatment programme, 
Antiretroviral Treatment (ART) and a Cancer Programme. The one with the 
least cost and the highest outcomes is the most cost effective option to use.   
 
 
Table 5: Types of Economic Evaluation Studies and their Valuation of costs 
and consequences  
 
Source: Baghbanian & Esmaeili (2012) 
 
Budget impact analysis 
Methods
Measurement and 








In a CMA, the consequences of two or 
more interventions being compared are 
equivalent. The analysis therefore focuses 
on costs alone, and the cheapest option is 
chosen. 
Monetary Units None
None; only inputs are 
compared; outputs are 
assumed to be equal, which is 
rarely so




An economic analysis to compare 
interventions that have a common health 
outcome; it attempts to measure a clinical 
output, such reduction in blood pressure, 
or quality of life. 
Monetary Units
natural effects, physical units 
or clinical outcome (e.g. life 
years gained, reduction in 




ratio (eg, dollars per 
life year gained)
Cost-Utility Analysis 
Often interventions impact both on quality 
and quantity of life. A CUA can be used 
where outcomes are valued on individual 
preferences (QALYs Gained). 
Monetary Units
Single or multiple effects, not 
necessarily common to both 
alternatives
Health state values what is so 
called health years (e.g. 
healthy years or quality 
adjusted life-years gained)
Cost-utility ratio (eg, 
cost per QALY)
Cost-benefit analysis 
In a CBA, attempts are made to value all 
the costs and consequences of an 
intervention in monetary terms. If the 
benefits are less than the costs then the 
intervention is acceptable. 
Monetary Units (Dollars)
Single or multiple effects, not 
necessarily common to both 
alternatives
Monetary Units (Dollars)
Net gain or loss in 
dollars
Cost-consequence analysis 
An economic analysis where costs and 
outcomes are presented in a disaggregated 
form rather than a single measure. Monetary Units
Multiple outcomes presented 




Budget impact analysis is an extension of costing. It  introduces a fixed or non-
fixed amount of resources which needs to be adhered to deciding which 
alternative strategy to take when choosing programmes. The budget is usually 
designated to a certain programme or services e.g. Antiretroviral Treatment 
(ART). With the ART budget the chosen strategies give 2 or more treatment 
paths should absorb the given budget.  
 
However, most cost evaluations are done on a fixed budget which tends to result 
in suboptimal decision making. It is important to include costs that are outside 
the budget given their potential to destabilise the stipulated budget of that 
period. Policy making depends on being given all the facts and not half of the 
story.  
 
2.2.1 Theoretical Literature Review of Costing 
It is imperative to note that accounting and economic literature generally agree 
on the basic principles of costing. Generally, the costing exercise begins with 
conceptualization of a clearly identified decision problem. This process also 
includes the definition of the objectives of costing, the costing perspective to be 
used, as well as the time-frame (Mogyorosy and Smith 2005) 
 
It is also important to identify all the requisite resource items, and justify their 
omission from the cost calculation. In addition, measurability or ease of 
observation should not be solutions for resource identification (Brouwer 2001). 
There is need to include even those difficult to measure resources and find a 
way to measure them if they add value to the research. Over-inclusion and over-
exclusion can be a problem (Byford 2003).  
 
 
2.2.1.2 The Economic definition of cost and differentiations  
 
The backbone of economics is the scarcity of resources in a given environment 
which results in decisions having to be made on what is to be forgone to achieve 




economy where goods and services are traded using money, financial costs are a 
form of monetary measurement.  
 
In Economics, costs include all the financial costs, costs of donated goods or in-
kind services, and all opportunity costs. The online business dictionary states 
that economic costs consist of the opportunity costa and the accounting costs 
which are cash involved. The economic cost concept can be extended to health.  
 
There is increasing research interest on the impact of medical costs on 
households (WHO 2004). It has been observed that individual illness has 
significant, largely negative, implications for other household members 
(Sauerbon 1996). The discipline of health economics explores the costs to the 
health system and to the patients seeking health care including the opportunity 
costs of being ill.  
 
Thus, costs are generally divided into three categories: direct, indirect, and 
intangible costs (McIntosh 1996). Direct costs are those costs for which direct 
payments are made and include medical costs that are mainly borne by the 
health-care sector, and non-medical costs such as transportation and home 
modifications, which are incurred by the patients and their families, while 
indirect costs pertain to those for which no actual payments are made but for 
which resources are lost (Leardini et al 2002). These are often classified as 
either morbidity or mortality costs and thus, the conceptualization of costs 
depends on the costing perspective (Wolfe et al., 2005).  
 
Intangible costs refer to costs that are difficult to measure such as pain, 
discomfort that emanates from sickness and treatment. They cannot be easily 
quantified as they are not actual resources. They are however, ways of valuing 
intangible costs such as willingness to pay (how much is one willing to pay to 
eradicate the pain or feel comfortable) and quality of life measurement (IQWiG, 
2009). These methods are meant to convert non-marketed goods and services 





2.2.1.3 Costing perspectives 
From whose perspective an economic evaluation is being conducted detects the 
types of costs that should be taken into account, e.g. have implications on 
whether direct non-medical costs should be taken into account (Jegers2002). 
Furthermore, the perspective will also determine whether productivity costs 
should or should not be taken into account, as well as whether service 
providers’ overheads should be added to direct medical costs or not (Payne 
2002).  
 
In costing perspective, the productivity loss for health providers is limited to 
those who pay for sick leave and pay health insurance, patient perspective is 
limited to patients’ loss of income and sick leave paid for by the employer 
(Lensberg et al. 2013). 
 
Since healthcare economic evaluation is conceptually based on welfare 
economics, it has therefore been argued that economic evaluations should adopt 
a societal perspective to be able to evaluate the impact on society as a whole 
(Byford & Raftery 1998, Byford 1998). A societal perspective costing includes all 
parties affected by the intervention i.e. health providers and the patients as well 
as the community and takes into account all the outcomes and costs regardless 
of who experiences them (Gold, 1996). Table 6  shows the inclusion and 





Table 6: Inclusion and exclusion of costs by perspectives  
 
Source: Luce 1996 
 
In general, identifying and valuing all the costs from a societal perspective can 
be challenging but analysts should do their best to identify measure and value 
resource use where it is possible in an economically feasible way (Green 1999). 
During a societal perspective costing, it is important to be weary of some costs 
causing measurement challenges when they do not have a major impact on the 
study results such as calculating building costs in a scale up programme 
(Drummond et al., 2005).   
 
However, there has been a decrease in economic evaluations from the societal 
perspective with most studies focusing on the provider perspective 
(Johannesson, 1995). The reason for most scholars concentrating on provider 
perspective is the popularity in measuring/assessing relative efficiency of 
alternative health care (European School of Health Economics - HEPaMI 2009).   
It has been argued that adopting a patient perspective for an economic 
evaluation may create a bias towards the social benefits of health care 
(European School of Health Economics - HEPaMI 2009). Some scholars note that 














Productivity costs Included Excluded Excluded None 
Informal carers Included Excluded Excluded Excluded 
Transportation All If any paid If any paid Excluded 
Other  non  health 
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If any paid + 
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n costs 









if economist value health benefits from a social perspective therefore so should 
the costs related to offering health care(European School of Health Economics - 
HEPaMI 2009). 
 
2.2.1.4 Costing Methodology: Micro costing versus Gross-Costing 
 The approaches to resource consumption measurement vary widely and may 
be determined by the aim of the cost analysis and by the availability of data. On 
one hand, there is the direct measurement of patient-specific resource 
utilisation, commonly called micro-costing, activity based costing or the bottom-
up approach (Smith 2003).  
 
While on the other hand, is the estimation of resource utilisation and costs by 
assigning a national average figure on non-patient specific bases such as using 
Diagnostic Related Groups (DRGs), or Healthcare Resource Groups (HRGs) 
based on national or regional administrative databases; commonly known as 
the gross-costing or top-down method (Brouwer 2001). The choice between 
micro-costing and gross-costing approaches has consequences for the 
identification of resource items and the measurement of resource utilisation 
(Smith 2003).   
 
In gross costing, health services are divided into large components intermediate 
products and these large cost items have to be identified (Brouwer 2001). Thus, 
gross-costing can be simple and transparent (Luce 1996). The result may be 
externally valid, and may be able to tackle regional or institutional variability. In 
addition, cross costing is usually faster and cheaper than micro-costing, but may 
be less accurate, because relatively large resource units are measured (Smith 
2003). Less precise costing, however, could negatively affect decisions related to 
patient care as well as health policy (Luce 1996).   
 
On the other hand, in micro-costing, a very detailed service delivery process is 
established and all the relevant resource items identified and measured 
separately (Brouwer 2001). Micro-costing frequently use measurement 
techniques developed by other industries, such as time and motion studies in 




analysed separately (Smith 2003). Therefore, micro-costing could be more 
reliable and precise, but it could be expensive and may not always be practical 
(Brouwer 2001). However, it may be the preferred method when gross costing 
is a poor estimate of resource utilisation (Luce 1996). A decision on the 
precision of resource utilisation measurement can be influenced by the possible 
impact of uncertainty the particular resource utilisation could have on the 
decision (Drummond 2005). It should however be noted that the end user of the 
economic evaluation results may influence the type of costing carried out.  
2.2.1.5 Measuring the Resource Utilisation of each cost element  
There are several ways to calculate unit costs, although most methods follow 
the full absorption cost principles (Zimmerman 2003). This means that all costs, 
both direct and indirect, relating to the provision of a particular service is 
included in the cost calculation (Brouwer 2001). There is a consensus about the 
fundamental principles of cost allocation (Green 1999).  
 
Ideally, costs should be traced directly in an economically feasible way (Wolfe et 
al., 2005). In essence, indirect costs should be allocated to service areas based 
on actual utilisation or cause-and-effect bases (Mogyorosy and Smith 2005). 
Drummond divides the costs incurred during screening in the health care, 
patient and family costs and other sectors.  
2.2.1.6 Costs from the provider (Health systems) perspective  
A provider (health systems) perspective relates to the costs incurred by the 
health sector in the quest for delivering health care to the public. The costs are 
from the provider of health care perspective, i.e. incurred by the provider. These 
are divided into direct and indirect costs. Below is further explanation on direct 
and indirect costs 
 
Direct costs incurred by the health system  
Direct cost incurred by the health system can be materials, labour, or expenses 
(Zimmerman 2003). Thus, the direct costs incurred by the health system include 
overheads, capital costs, and equipment (Johnston 2001). Hence, depending on 
the essential infrastructural requirements, health system services can be 




peripatetic services (Beecham 1995). Furthermore, they can be divided into 
patient related costs and non-patients costs/ programme costs (Benjamin et al., 
2003).  
 
In a discussion about rapidly rising healthcare costs, inevitable attention turns 
to the pricing of medical services and products. While current prices may 
preserve incentives for innovation and reflect investments in research and 
development (Jayadev and Stiglitz, 2009), these prices may also reflect market 
asymmetries in information and monopoly power (Dafny, 2009; Pauly and 
Burns, 2008).  
 
In practice, identifying most of the direct costs incurred by the health system is 
generally straightforward and easy, although some of them can be a little bit 
problematic, and a few of them very difficult (Zimmerman 2003). For instance, 
some of the overhead costs, such as training costs, supervision costs, and 
administrative overheads are frequently omitted from the cost calculation 
(Johnston 2001). Likewise, the identification of joint costs is crucial, but 
challenging (Yazbeck 2001).  
 
The concept of capturing direct costs incurred by the health system means that 
all the relevant resources used are taken into account during the cost 
calculation (Beecham 2005). This is essential for accurate cost calculation, 
although, in practice, it could be very challenging (Smith 2003). For instance, a 
doctor treat several patients in the intensive care unit, therefore it is necessary 
to apportion a doctor’s salary between patients to estimate the real as well as 
correct costs of the treatment of a patient in the intensive care unit (Bean 1996).   
 
 Discounting and annualisation of direct costs  
Training is considered a future investment and is discounted and annualised 
accordingly. Capital costs are annualised to ascertain the cost in the year of 
assessment given they will be used over a longer period of time.  
 













                      PV = the present value; t = the period in which the 
costs occur; r i=the discount rate. 
 
The rate at which to discount costs is controversial but there is a general 
consensus amongst economic evaluators.  
 
The French use the a social discount rate of at 4% as of 2005, assuming the time 
horizon is less than 30 years, reducing up to 2% thereafter (Haute Autorite de 
Sante 2012). In a review of 147 economic evaluation studies conducted by the 
University of York the most commonly used rates for health costs were 3% and 
5%, whilst some studies used 0% (Smith & Gravelle n.d.). Using the 3%-5% 
annual rate since it has been used in most of the published material will give 
room for referencing and comparison (Drummond 2005).  
 
Indirect costs to the health system 
On the other hand, indirect costs to the health system have no direct 
relationship to the cost object; therefore, they cannot be traced to the cost 
object easily or in an economically feasible way (Yazbeck 2001). Indirect cost to 
the health system may include materials, labour, or expenses. For instance, the 
cost of catering or cleaning in a hospital, as well as the cost of clinical audit, is 
classified as indirect costs of health services (Smith 2003).  
 
In addition, the cost of cleaning personnel or security is usually classified as 
indirect labour costs to the health system (Wolfe et al 2005). The costs of 
materials used to clean the wards are also classified as indirect material costs to 




2.2.1.7 Costs from the Patient perspective  
A patient perspective relates to the costs incurred by the patient and the family 
in the quest to get treatment from the health care sector. These are divided into 
direct and indirect costs and intangible costs. Below is further explanation on 
patient direct and indirect costs.  
 
Direct costs incurred by the Patients 
Direct costs are incurred by the patients as a consequence of out of pocket 
payments paid for seeking treatment at a health care facility, purchasing of 
drugs and transportation to the health care facility (Segel 2006). The patient 
direct costs include transport costs, food costs, and any payment for child care 
during the referral visit. Economists generally agree on how to measure direct 
costs of patients as they are easily quantifiable. However, indirect costs incurred 
by patients whilst seeking treatment are debatable in terms of measurability.  
 
Indirect costs to the Patients  
Indirect costs include time costs, opportunity cost of the referral, lost 
productivity which could be measured in terms of wages lost. More explicitly 
they consist of the opportunity cost of time lost due to morbidity (Zimmerman 
2003), loss of productive time as a result of seeking health care services, which 
is inclusive of the time spent in hospital; time spent queuing at the hospital and 
the time travelling to and from the hospital (Segal J, 2006). These factors affect 
the patient attendance for a screening, monitoring, and referral.  
 
The human capital theory is the most commonly  used method for valuing 
productivity costs and it is based on neoclassical economic theory, which states 
that profit-maximizing firms employ workers up to the point where their 
marginal contribution to production equals their gross wage (Merkesdal et al., 
2001). Economic evaluation method is informed by the human capital and the 
friction costs methods (Haute Autorite de Sante 2012). Human capital entails 
giving value to potential productivity loss whilst the friction costs method 
calculates the loss of production due to absence at work (Haute Autorite de 





The productivity of individual workers is a critical factor of workplace 
productivity, and is directly affected by an illness (Escorpizo et al., 2007). 
Worker productivity is generally classified as either absenteeism or 
presenteeism (Brouwer 2001). Absenteeism is defined as productivity loss due 
to health-related absence from work, and includes sick days, personal time off, 
and time taken as short or long-term sick leave (Kessler 2008).  
 
Methodological concerns of indirect costs quantification 
A variety of studies have used the human capital theory to estimate productivity 
loss by multiplying the cumulative number of missed workdays by a daily salary 
(Verstappen et al., 2005). The ethics associated with the use of individualized 
wages has been questioned as this approach leads to the identification of 
patients with lower incomes, and a preference for treating patients with higher 
incomes (McIntosh 1996).  
 
In addition to productivity losses arising from gainful employment, housewives, 
retired people, and students also incur substantial productivity losses called 
Household productivity costs (Verstappen et al., 2005). Household productivity 
costs have been found to account for up to 88% of total productivity costs, 
suggesting that loss of household productivity might actually exceed that of paid 
productivity (Koopmanschap and Rutten 1996).  
 
The productivity loss for health providers is limited to those who pay for sick 
leave and pay health insurance, patient perspective is limited to patients’ loss of 
income and sick leave paid for by the employer (Lensberg et al., 2013). 
Collection of information is usually done collecting official attendance records 
from the employer or relying on the workers noting how many days they spend 
at work, However it’s been noted that relying on employee self-reporting of 
absenteeism may result in overestimating costs (Lensberg et al., 2013).  
 
Debates on indirect costs measurements 
Significant debate exists not only around the issue of whether indirect costs 
should be taken into account in an economic evaluation, but also on the proper 




health Institute and Personal Social Services does not allow for the inclusion of 
productivity costs in its economic evaluation (Lensberg et al., 2013).  
 
However, Canada and Australia allow the inclusion as long as they are evaluated 
separately (Lensberg et al., 2013). The Swedish and Dutch allow for the 
inclusion of costs related to production loss. The Swedish recommend the use of 
the Human Capital method, whilst the Dutch, Australians, and Canadians 
recommend the use of the friction cost method (Lensberg et al., 2013). The 
friction cost method was therefore proposed as an alternative approach to the 
human-capital theory (Koopmanschap & Rutten 1996).  
According to the friction cost approach, productivity losses still occur but are 
confined to the period until a previously unemployed individual is able to 
replace the absent worker (Escorpizo et al., 2007). Since the amount of 
production lost as a result of a disease depends on the time organizations need 
to restore the initial production levels, it is argued that the friction cost method 
provides a more realistic picture of productivity loss occurring to a society with 
an increasing number of health economists arguing that this method reflects 





The Human capital and Grossman theorem  
Production within an economy is known to be made possible by the following 
components; capital (machinery and other equipment’s), buildings, and land 
( Singh 2014). Most importantly humans are responsible for putting these 
components together for production to be successful.  
 
The Human Capital theory assumes that humans should be equated to capital 
since they also help in the production of goods and services. Because there is 
time involved, humans can allocate their time to production, labour, or leisure. 
In the event of sickness, the time has to be altered involuntarily to accommodate 
health seeking (Howitt 2005). Poor economic growth in developing has been 
attributed to poor health due to HIV/AIDS, malaria, Tuberculosis amongst 
others.  
 
Investment in human capital is assumed to help increase production and an 
employer may do so by providing education, training, and sick leave to the 
employees who alters the time for labour and leisure. As noted above, to 
estimate productivity lost, the cumulative number of missed workdays is 
multiplied by a daily salary i.e. Human Capital theory uses wages as a proxy to 
employee output. 
 
The Grossman theory is an extension to the Human Capital Theory which values 
human capital for its future earning potential only. The Grossman theory states 
that one should invest in health to avoid early death. This stems from what 
Grossman terms the realisation that ill health results in loss of productivity in 
supply of labour as well as the realisation that  though consumers pay for 
services in health care, they in actual fact pay for good health. He goes on to 
distinguish between consumption of health and investment for Health. 
Consumption is noted to provide direct utility to the individual who can choose 
to seek treatment or not. Lack of health is a disutility and this is presented in a 





   
C represents the consumption and H the stock of the individual’s health. Utility 
of C and H are assumed positive though diminishing form time 0 to time T 
(Laporte 2014).   
  
Grossman (1972) disputes Malthusian theory that noted any increase in income 
increased the chances of a healthy being since they have more money at their 
disposal for nutritional foods and health care access (Grossman 1972). 
Grossman notes that in developed countries, Malthusian Theory does not hold 
true due to fluctuations in income making an individual vulnerable to mortality 
and morbidity.  
 
The Grossman theory has faced several criticisms. Galata et al (2012) argues it 
does connect current health behaviour with the patient’s history and it ignores 
the fact that a lower socio-economic status results in a decline in health status. 
Zweifel (2012) notes that it ignores the fact that humans don’t live forever, 
assumes positive health outcomes if there is an investment in health which does 
not hold true in real life and (Laporte 2014). More so, it does not take into 
account individuals who have suffered a major health illness.  
 
The friction cost method on the other hand uses replacement cost of the 
employee as a proxy to output in calculation production loss. The replacement 
costs include advertising for a replacement worker, recruiting, and training him. 
It has been criticised for being cumbersome and  needing too much information 
in comparison to the Human capital cost method proponents (Laporte 2014).  
 
The next section reviews the empirical findings with respect to the monitoring 




2.2.2 Empirical Literature Review  
 
2.2.2.1 Costs from a health systems perspective  
A review of Popline, Medline and donor websites databases reviewed that they 
were not many cost effectiveness, cost utility, cost benefit and cost analysis in 
the field of maternal health (Borghi n.d.); and the introduction of new 
technology into the healthcare system, specifically ultrasound machines ( 
Henderson 2002). There were more clinical studies but were not followed up by 
the economic evaluation (Borghi n.d.). Below is a review of the few that were 
available.   
2.2.2.2 Costing methods  
As noted in the theoretical literature, the type of costing method determines the 
information that will be used in the costing exercise. This will ultimately affect 
the outcome under review e.g. the average cost per patient.  
 
A costing analysis study whose main objective was to estimate the, “distribution 
of costs incurred on the Primary Health Centre, by service provided at a primary 
health care centre, Chhainsa in Haryana, revealed that 11% (US$ 2668) of the 
total costs incurred during a 1 year period were attributable to maternal care 
i.e. Indian rupee 127 average cost per patient (approximately ZAR 23) (Anand 
et. Al., 1995). No economic costs (outcomes/benefit measurements) were 
included which may undermine the results for their lack of showing the true 
economic cost and exploration of the societal perspective.  
 
In a cross sectional study using a step-down allocation approach which included 
both capital and recurrent costs, the average cost per ANC visit in Ghana from 
the health care perspective was US$18 (Dalaba et al., 2013).  Like South Africa, 
Ghana offers free Antenatal Care (ANC). The amount may be deemed inaccurate 
due to the use of step-down approach in which cost data was extracted from the 
health centre budget and the ANC component allocated as per usage i.e. did not 
reflect the actual ingredients2 used in ANC. Average costs of operating an ANC 
were approximately US$23,063, which were considered high due to the lack of 
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utilisation of services. It is critical to distinguish whether the unit costs are high 
due to under or over utilisation of services. This is because it affects the 
efficiency ratings of the health care centre. 
 
 A cost effectiveness study of one-stage ultrasound screening in pregnancy in 
the Helsinki ultrasound trial by Leivo et al (1996) included the lack of utilisation 
of facilities in their study by representing them as negative costs in their model. 
The results of the Helsinki Random Controlled Trial revealed the unit cost of an 
ultrasound to be $102 when positive costs were assessed. The avoidable cost of 
a perinatal death due to ultrasound monitoring was US$21 938. Having 
combined the negative costs and positive costs the cost saving to the health care 
system amounted to US$ 17.  
 
Ultimately, One-stage second-trimester ultrasound screening with more time 
spend during the ultrasound administering examination was noted to be cost 
effective due to the inclusion of the significant costs and effects.  
2.2.2.3 Direct and Indirect costs to the health system  
The inclusion of recurrent costs and capital costs has its own strengths and 
weakness. Whether it is ideal to exclude certain cost items depends on the 
perspective of the study, the outcome required, if it is incremental costing or 
scale up costing amongst other things. 
 
 In some studies, overhead costs, such as training costs, supervision costs, and 
administrative overheads are frequently omitted or included from the cost 
calculation (Johnston 2001) as well as capital costs such as buildings, vehicles, 





Table 7: Economic evaluation studies and their costing ingredients  
 
NB: X shows the ingredient was included. 
Source: Authors compilation  
 
The objective of Kranzer et al.,(2012) was to analyse the cost of, “adding TB 
screening using sputum induction to the existing mobile HIV testing service,” 
(Kranzer et al. 2012) i.e. an incremental costs analysis which focused only on 
financial costs. Economic costs were excluded. It was a provider based study 
therefore did not include any patient costs.  
 
Capital costs for equipment and transport were considered, annualised, and 
discounted at 6% whilst recurrent costs such as staff, consumables, laboratory 
tests, office rent, and overhead were also included. Time and motion studies 
were done to determine staff costs and apportioned appropriately with time 
spend on patients. It would have been interesting to include patient costs in 
order to understand the cohort’s economic and financial costs towards TB 
screening as well as obtain a social cost of the programme. 
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A cohort study to ascertain the cost of hospitalisation before and after 
antiretroviral initiation, used the patient per day rate (PDE) which is 
predetermined by public hospitals’ districts (Meyer-Rath et al., 2013). It was 
calculated by dividing the total expenditure of the hospital for the financial year 
with the number of patient visits. This however, may result in inaccurate 
estimates because it assumed the rate was not far removed from that of HIV 
patients which maybe the case. They do however give a justification of their 
decision to use PDE.  
 
Desmond (2004)’s cross sectional - costing exercise of the national PMTCT 
protocol was conducted in four pilot sites across South Africa (Desmond et al., 
2004). The costing ingredients included staff, drugs, facility (e.g. renovations of 
the buildings), baby formula, and training costs. Interesting, is the inclusion of 
training costs which they discounted and annualised for 5 years whilst the start-
up building costs life years were set at 15years.  
 
Like South Africa, Ghana offers free ANC. A cross sectional cost analysis study in 
Ghana whose objective was to cost maternal health services in Selected Primary 
Care Centres included vehicle costs in the capital cost list (Dalaba et al., 2013). It 
followed a step-down allocation approach, and the average cost per ANC visit in 
Ghana from the health care perspective was US$18 (Dalaba et al., 2013). The 
exclusion could have attributed to the increased unit costs given that the 
annualised costs of owning the vehicle would be higher with less utilisation by 
patients. 
 
A modelling study by Patterson (2011) which sought to calculate the cost of 
scale-up of care for mothers and babies at the health-system level to prevent 
stillbirths. The Lives Saved Tool’s resulted noted the preferred outcome to be 
between $0.96 $US 2,32 per pregnant woman monitored using ingredients 
costing of recurrent costs only, i.e. no capital costs was included (Pattinson et al. 
2011). The exclusion of capital in the costing is a great limitation to the study as 
equipment such as ultrasound imaging is an essential part in determining the 
possible outcomes of the fetus. Possibly, lack of cost of the equipment may have 




been deemed as causing measurement challenges as noted by Drummond 
(2005).  
 
In some cases, including all types of costs gives the opportunity to identify cost 
pushers or cost saving areas. A cohort study at Liverpool Women’s Hospital 
whose objective was to detect fetal abnormalities by routine ultrasound and the 
related costs conducted a cost effectiveness study (Henderson & Martin 2000). 
Primary costing included staff, equipment, disposables, and capital costs.  
 
The study revealed the underutilisation of equipment but a need for extra staff 
due to increase routine scans. In the second phase of the study more staff was 
employed to help with the routine scanning and no equipment was purchased. 
The cost of introducing routine scanning was costed to be equivalent to £16 per 
pregnant woman. The  cost of ultrasound for growth abnormalities to be 
approximately £15.71 (£13.58–£17.84) whilst for fetal well-being scan cost 
£15.46 (£11.67–£21.16) (Henderson & Martin 2000).  
 
 On the other hand, hospital costs were estimated to be 11% of the recurrent 
costs and these were apportioned to the programme. Such apportionment risk a 
danger of underestimating or over estimating the overheads costs of the 
programme and in-turn bias the final unit cost for the evaluation. Time taken 
per scan was recorded on diaries and training times were also captured. Staff 
costs were calculated by apportioning time spent by each staff member of ultra-
sounding duties to their salaries. Average time spend on clerical duties during 
scanning was 5 minutes whilst average time for conducting the anomalies scan 
was an average of 15 to 20 minutes which is not different from the Long and 
Sprigg (1998)  study.  
 
However, there was no mention of training being discounted costs which 
weakens the study in terms of accounting for future benefits from training the 
staff. This is the recommended way by most health economists and is meant to 
give a true reflection of staff costs. Interesting is the addition of 6% onto capital 
as a return of investment on top of the 7% straight line depreciation and 





Type of Hospital and location’s effects on direct and indirect costs 
Location and level of hospital is a key factor in costing exercises. They are 
differences in cost within the different levels of the public hospitals. Some items 
are donated to the hospitals and have to be costed using either health market 
prices instead of actual purchase prices. This may inflate the cost. In most 
developing countries, mission hospitals receive donated goods.  
 
A costing study of maternal health care in Blantyre district, Malawi revealed the 
complexities of different facility arrangements (Levin et al., 1999). The costs at 
public hospitals were noted to be higher than those at mission hospitals, an 
inverse to most studies which found mission hospitals to be less costly. Public 
hospitals had unfair advantage of having highly qualified staff and more support 
staff which meant higher staff costs.  
 
However, drugs were much cheaper at public hospitals to due to subsidising by 
government. Referral hospitals also saw more patients resulting in higher unit 
cost. Overall, the cost of ANC ranged between US$5.00 to US$6.00. Furthermore, 
the use of more drugs at the hospitals increased the costs at in comparison to 
the public health centres (Clinics). It notes that the different facilities, drugs, and 
supplies constituted the bulk of the costs whilst in comparison to other services 
indirect costs were lower for ANC. 
 
Overstaffing and underutilisation are some of the key factors that affect the 
calculation of unit costs rendering them high or low. The unit costs emanating 
from these studies are used in resource allocation and it is important that they 
be as accurate as possible. It is not clear cut to state that a low/high unit cost is 
the best to show efficiency of a clinic or hospital. It may be due to overstaffing or 
good delivery of services which may be requiring more items As noted in the 
Ghana study (Dalaba et al., 2013), underutilisation resulted in high unit costs.  
 
A cost analysis of maternal health care in the South of Tanzania showed gross 
underutilisation of clinics resulting in higher unit costs in comparison to 




US$12.30 in a clinic. Cost of consultation for ANC was relatively low at US$2.50 
(von Both et al. 2008).   Sensitivity analysis has been conducted on utilisation in 
several studies to check how increase or decrease in utilisation of facilities or 
service affects the costs or cost effectiveness. Such results are important in 
optimal decision making.  
2.2.2.4 Costs from the patient perspective  
Patients incur costs in seeking treatment and these are divided into direct and 
indirect cost as noted in the theoretical literature review. The direct costs are 
further divided into the medical and non-medical expenditure. The medical 
expenditure includes consultation fees, payments for drugs and investigations 
whilst non-medical costs include transport, food, guardian, and lodgings. 
 
 These are termed household costs and the family needs to manage these and 
avoid not falling into the poverty trap where one finds it difficult to escape 
poverty. Failure to manage health costs results in patients seeking alternative 
treatment or deciding to go untreated as noted by the Model of Patient Pathway 
to Treatment Conceptual Framework (Walter et al., 2012) 
 
The cost of screening affects the attendance by a patient. In a household study in 
Nepal, to ascertain the cost of illness (maternal health), the cost of a home 
delivery ranged from US$5.43 to US$11.63 with the help of a friend/relative or 
health worker respectively. In comparison the cost of a normal delivery at the 
hospital cost the family US$8.97 whilst a caesarean section cost US$150 and 
above depending on possible complications. With the inclusion of opportunity 
costs and transport costs the normal delivery at the hospital amounted to US$70 
and above. 
 
 In the study conducted in London on cost implications of introducing a 
telecardiology service for fetal ultrasound screening, London women incurred 
an average of £37 in comparison to  £5.50 for the telemedicine referrals (Dowie 
et al. 2008). The costs were collected through postal surveys. In some instances, 




However, patient interviews are always marred by recall bias considering the 
time lost between interview date and date of clinic or hospital visit.  
 
There has been a great debate in including opportunity costs in the final patient 
cost due to the difficulty and non- standardised way of measuring that aspect of 
the study. Torgerson, Donaldson, and Reid (1994) assessed the differences 
between private and societal opportunity costs and concluded that the private 
opportunity costs were a more reliable predictor of the demand for screening 
services. As noted in the Nepalese study, there is an increase from US5.43 or 
US$11.63 to US$70 when the opportunity costs and transport costs are included 
which is quite significant. However, to gather the true economic costs it is 
essential to include opportunity costs as per the Human Capital and Grossman 
theorems.  
 
2.2.3 Effectiveness of Monitoring IUGR and SGA  
 
Several studies have been conducted to assess the clinical effectiveness of 
intrauterine growth retardation monitoring with regards to finding clinical 
solutions in order to reduce perinatal mortality or morbidity (Henderson & 
Martin 2000) . Most of the studies compare the different strategies of 
monitoring IUGR and SGA against no monitoring at all. The study samples 
include women with high risk pregnancies stemming from previous still births, 
hypertension, diabetes and those who would have been noted to have IUGR.  
 
However, most studies concentrate on the second trimester more than the first, 
limiting the range of assessing effectiveness of monitoring from early on in the 
pregnancy. The monitoring strategies in most of the studies include monitoring 
of Body Mass index (Haws et al., 2009), SF measurement by tape measure and 
Doppler ultrasound (Henderson & Martin 2000; Marsál 1994; Stampalija et al., 
2010). Ultrasound screening is considered to provide more information 
regarding SGA and IUGR than the BMI and tape measure strategies allowing for 





Some studies noted there is a value in monitoring high risk pregnancies 
especially those with suspected placental dysfunction using the Doppler 
ultrasound (Henderson & Martin 2000; Haws et al., 2009; Marsál 1994).  
However, a Cochrane review of Randomised and quasi-randomised controlled 
trials of Doppler ultrasound versus no Doppler ultrasound revealed that there 
was no evidence of the mother or fetus benefiting whether the Doppler was 
performed or not on second trimester women in two of the studies reviewed. 
They however, recommended that more reviews be done on first trimester 
women (Stampalija et al., 2010) as they could be a potentially opposite result.  
 
 Consequently, 16 studies reviewed collectively suggest that perinatal mortality 
can be reduced by 29% [RR 0.71, 95% CI 0.52-0.98] if Doppler monitoring is 
used together with other appropriate interventions. Despite the result, the data 
was not statistically significant.  
 
Waitzman (1998) noted there was uncertain social benefits to routine screening 
for fetal anomalies with the benefit to cost ratio ranging from 0.33 to 3 
(Waitzman et al., 1998)  . Mores studies in this area would provide more insight 
in the area of monitoring IUGR and SGA especially by ultrasound and tape 
measure.  
 
2.2.3.1 Studies on Introducing Ultrasound in Low Resource Settings  
Tape measures and ultrasound machines are used to monitor IUGR and SGA. A 
systematic review by Harris and Marks (2009) revealed that there are not many 
studies dealing with the introduction of compact ultrasound in low resource 
settings, namely developing countries. In their findings they note that evidence 
based analysis in those areas has been hampered by the lack of useful 
information on perinatal and maternal morbidity and mortality as well as lack 
of effectiveness studies on the compact ultrasound in comparison to full sized 
unmovable ultrasounds. They recommend such studies be carried out. This 





A study conducted in Tanzania‘s Lugufu refugee camp between 2005 and 2007 
revealed that it was feasible to introduce a portable ultrasound unit in a low 
resource setting (Adler et al., 2008). Out of the female cohort, for 24.1% of the 
total were pregnancy related exams. A study in a Ghana also revealed the 
feasibility of a portable ultrasound in 2 different settings, i.e. 2 primary care 
sites and 2 hospitals (Spencer and Aldler, 2008). 29% of the cases were related 
to abdominal, pelvic, and genitourinary. In the hospital setting the range of 
ultrasound examinations was much wider, showing how an ultrasound machine 
is of multiple uses similar to the full sized ultrasound machines in the secondary 
and tertiary hospitals in our study. It alluded to the issue of using an allocative 
factor to apportion the costs related to the type of examination performed by 
the ultrasound machine.  
 
Kongnyuy et al., (2007) notes the importance of not only training doctors to use 
ultrasound in obstetrics but to also train midwives (Kongnyuy & van den Broek 
2007).  Task shifting from sonographers, to nursing staff was noted as an option 
in the studies regarding introducing portable ultrasounds in low resource 
settings (Adler et al., 2008).  
 
The World Health Organisation provides guidelines of training sonographers 
and general practitioners (Kurjak & Breyer 1986). A study in a rural setting in 
Rwanda, ultrasound training on maternal health was offered to the local 
physicians and the quality assessment showed 96% accuracy. The Ghana study 
mentioned above used a skilled radiologist.  
2.3 Lessons and Gaps derived from the literature 
 
The literature review identified gaps in terms of maternal costs within South 
Africa. The cost for antenatal care in public health care centres in South Africa of 
US$7.24 ($5.78-$8.70)  noted in Jinabhai et al was for the year 2000 (Borghi 
(n.d.)), and there don’t seem to be any studies accessible on the public domain 
going forth. It is interesting that with all the talk of reaching the millennium goal 
on child and maternal health, no one has bothered to come with a cost covering 




widely published that financial constraints on the patients result in most of 
them not attending antenatal care.  
However, not much effort has been done to cost a financial burden per visit to 
the ANC. The economic impact on the introduction of the Umbiflow machine 
into the primary health care intends to calculate the cost per visit to the ANC 
and to a referral for further monitoring.  
 
More so, there have been limited studies on the cost effectiveness of an 
introduction of a new machine for maternal care. As noted in the previous 
section, clinical effectiveness studies have been done on introduction of 
ultrasounds including portable ones in low resource settings. A literature search 
for similar cost studies yielded no study. A systematic review by Harris and 
Marks (2009) revealed that there are not many costing studies dealing with the 
introduction of compact ultrasound in low resource settings (Harris & Marks 
2009). 
 
 Most studies evaluated clinical effectiveness but did not explore the economic 
impact. The Umbiflow study aims to cover part of this gap. It will also provide 
comparative material in case of similar studies in the future. To our knowledge, 
this will be the first detailed costing study of an antenatal technology 
intervention programme in South Africa context, and though a pilot study, it will 
provide strong insights into possibilities of benefits of introducing a reasonable 
cheaper technology in low resource setting that could improve antenatal 
outcomes.   
 
Given the fact that the evidence in the current study on cost effectiveness of the 
introducing the Umbiflow is from a pilot study with limited population study 
group which also lacks a proper comparison group, a full economic evaluation of 
antenatal procedure as well as the introduction of the personal computer (PC)-
based, continuous-wave Doppler machine (the Umbiflow® machine in the 
primary health care setting should be undertaken to provide a full picture of 
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Umbiflow is a sophisticated but easy-to-use Doppler with bi-directional indication of 
blood flow velocity in the umbilical cord. The Doppler measurement is used to 
recommend specialist intervention should the fetus be at risk. The project was 
motivated by the status quo in South Africa is which Doppler interventions are only 
available at higher levels of care, and thus require patient referral.  
 
Study Objective  
The objective was  to study the costs associated with using an Umbiflow Doppler 
analyser at primary antenatal care facilities from a societal perspective.  
 
Methods  
A pilot study was carried out on a cohort of 131 pregnant women with suspected low 
Symphysis Fundus. A retrospective cost analysis was conducted on 41 out of the 66 
pregnant women, referred to a higher level hospital from Kraaifontein and 
Durbanville Clinics, between April 2013 and March 2014 using structured 
questionnaires. Health provider and societal cost perspective were adopted. The costs 
were calculated in 2013 Rand value. 
 
 Results 
The average cost was  higher for secondary hospital visit for Doppler screening 
(R194.77) compared to R73.62 for a visit to the primary health care. From the health 
system perspective, the cost was 722.28 rands and 6709.78 rands in the primary 
health care setting and hospital respectively. Doppler screening strategy in hospital 
level proved less cost-effective than clinic based Doppler strategy,  
 
Conclusions 
The evidence provided strong insights into benefits of introducing a reasonable 
cheaper technology in low resource setting that could improve antenatal outcomes.   
 
Keywords: Umbiflow Doppler, Intrauterine growth restriction (IUGR), Symphysis 
Fundus, portable ultrasound, perinatal mortality rate Cost analysis  
 
3.1 Background and Setting  
The study focus was on introduction of technologies that help in diagnosing fetus 
intrauterine growth retardation (IUGR) due to placental insufficiency i.e. the 
placenta’s inability to provide sufficient blood flow for the fetus to continue growing 
relative to the standard growth curve which may result in death of the fetus if no 
treatment measures are taken i.e. perinatal mortality (Calhoun Rice, 2012). Perinatal 
mortality (PNMR) accounts for deaths during the period before the child is born 
(Stillbirths) and the first week of birth. It is calculated as the number of perinatal 
deaths per 1000 total births. (World Health Organisation, 2013) South Africa’s 
definition of perinatal mortality differed from that of World Health organisation 





Improvement of maternal health and reduction of child mortality form Goal 4 and 5 
of the Millennium Development Goals (MDGs) advocated by signatories to the 
United Nations in 2000, South Africa included (World Health Organisation, 2014). 
To achieve these goals it is critical that the mother and the fetus obtain medical 
monitoring during the 40-42 weeks pregnancy period to avoid disability or death of 
the child or the mother. It is during this period that a fetus may fail to develop or 
suffers slow growth as a result of several clinical factors and maternal lifestyle habits 
(Mook-Kanamori et al., 2010). A South African report, Saving Babies 2010-2011 
(Pattinson, 2013) , reported 32,178 still births in a 2 year period of January 2010 to 
December 2011 within the 94% of the total hospitals who provide data to a Perinatal 
Problem Identification programme (PPIP)((MRC 2014) 
  
 Fetal growth assessment is an important part of positive maternal outcome and the 
early detection of intrauterine growth restriction (IUGR). In South Africa, the 
protocol to follow when a woman tests positive for pregnancy, assuming the baby is 
wanted is noted in the Basic Antenatal Care (BANC) handbook (RC Pattinson, 
2007). A woman’s antenatal care (ANC) should begin during the first visit to the 
hospital to confirm pregnancy. From there onwards the fetus growth is monitored by 
nurses using a tape measure to measure the symphysis-fundal (SF) (Cronjé, Bam, & 
Muir, 1993b). The status quo of suspected cases of IUGR using the tape-rule 
measurement of SF height is an upward referral to the higher level care for Doppler 
ultrasound. As a result of the subjective referral, a number of cases are sent back to 
the primary health care (PHC) due to false alarm (false diagnosis noted as 2.5 times 
for every correct diagnosis or in some cases 5%) and thus both the health care system 
and the patients are exposed to avoidable cost and burden (Cnattingius 1985 & 
NCCWCH 2008).  
 
The introduction of technology into the PHC to assist human capital is seen as 
strengthening the Technology pillar of health systems. However, technological 
innovations are not always cheap and are usually confined to the secondary and 
tertiary institutions. Less costly technology in the clinics and community health 
centres (CHC) is likely to reduce hospital admissions by 44 %, caesarean sections 
due to foetal distress by 52% and possibly avert 20% of induced labour (CSIR, 
2013). The study focus is on introduction of relatively cheap technology that could 
help in diagnosing IUGR due to placental insufficiency (Calhoun Rice, 2012). 
 
The Council for Scientific and Industrial Research (CSIR) commissioned project has 
been instrumental in the testing of a miniature mobile ultrasound Doppler machine 
developed by Jeremy Wallis, Medical Research Council, CSIR and funded by the 
South African National Research Foundation for use in the lower level facilities 
(CSIR, 2003). It is meant for patients who do not present as high risk at the initial 
visits but with further monitoring are then suspected to have IUGR (CSIR, 2003). It 
is a miniature, portable ultrasound machine which doesn’t contain imagery of the 
womb. It uses continuous-waveform ultrasound to detect the blood flow within the 
umbilical cord of a fetus in conjunction with a computer/ laptop and does not need a 
trained and experienced sonographer (CSIR, 2003). It can be operated by trained 
midwives and nurses. A previous clinical study revealed the Umbiflow Doppler test 
run on the Pentium 3 PC which produced a normal flow velocity waveform was less 
likely to be followed by perinatal deaths (Hugo et al., 2007). However, no full cost 
analysis  study was done i.e. from the health system and the patient perspective. 
 
4 
3.2 Methodology   
3.2.1 Ethics Approval 
Ethical approval was provided by the University of Cape Town, Stellenbosch 
University, and the Western Cape Department of Health Research Ethics Committee. 
Only the research team had access to patient data and codes were used as individual 
identifiers for anonymity.  
3.2.2 Setting 
The study was conducted in the Tygerberg Eastern Health District of the Metro 
Region of Western Cape, South Africa at two primary health care facilities, one 
secondary level hospital, and one tertiary hospital namely Kraaifontein Community 
Health Centre (CHC), Durbanville Day Clinic, Karl Bremmer District Hospital, and 
Tygerberg Hospital respectively. The hospitals are all public institutions funded by 
the Western Cape Department of Health (WCDOH), one of South Africa’s 9 
provinces. The patients presenting at Karl Bremmer and Tygerberg hospitals are 
referred from Kraaifontein and Durbanville clinics i.e. they form part of their 
catchment area.   The pilot project was conducted during the period July 2013-March 
2014. The clinical study included an economics impact analysis of introducing the 
Umbiflow Doppler machine into the primary health sector, the results of which are 
reported in this report. The cohort of the clinical study was 139 patient stems from 
the sample size calculation by Dr. Justin Harvey at Stellenbosch University for the 
Umbiflow clinical study. The inclusion criteria for patient participation is poor SF 
growth and late bookers >28 weeks attending Kraaifontein Community Health Care 
Centre and Durbanville Clinic for antenatal services. All patients who met the criteria 
of suspected IUGR from Kraaifontein CHC and Durbanville clinic following an 
Umbiflow medium and high risk result were referred to Karl Bremmer or Tygerberg 
depending on case severity for further confirmation of the Doppler results.  
3.3 Costing Approach 
A societal perspective was adopted in the cost analysis. The costs were divided into 
two categories namely health systems and patient costs. The costs were calculated in 
Rand value, the South African currency at the year 2013 prices. Microsoft excel was 
used to analyse the data. The Doppler ultrasound administering to a patient at 
different levels of care will be costed.   
3.3.1 Patient costs 
The patient costs were collected through structured questionnaire and reflects a 
bottom up approach. To avoid recall bias, the team made an effort to interview the 
patients within the month of referral. Out of the 139, 66 had clear referral 
information and 41 were successfully interviewed for the economic study. The 
reminder either refused to be interviewed, or were not reachable on their phones or 
addresses due to either wrong telephone numbers supplied, or having moved from 
their original addresses. It was also difficult to identify some addresses due to the 
haphazard town planning of the suburbs.  
The patient direct costs,  included travel costs, refreshment costs, and any payment 
for child care substitute during the primary health care centers and referral visit; all 
reported in Rands .  
The reported time to travel and the waiting time were calculated for PHC visits and 




analysis included direct costs (travel costs and refreshments i.e. snacks and drinks) 
and indirect costs (travel time to the clinic and waiting time at the clinic). The 
indirect cost is therefore, the productive time lost or forgone income by not only the 
patients but also the caregivers is estimated. In order to quantify the time loss, the 
lost hours are monetized by multiplying the total number of hours lost by average 
hourly wage. However, the use of general average wage or an average wage of 
people with same characteristics as been accepted as proxy (Zhang et al., 2011). 
Due to the fact that over 75% of the patients were unemployed or with 
irregular jobs, with little education, the national minimum wage of domestic 
workers in 2013 (9.63rands per hour) was used as a proxy  
 
3.3.2 Health Systems Costs 
Incremental costs were assessed from the perspective of the health system in relation 
to introducing the Umbiflow Doppler ultrasound machine into the primary health 
care level. The costs assessed encompassed the health system related costs due to 
referral of patients to secondary and tertiary institutions. 
 
3.3.2.1 Consumables and Overhead Costs 
Micro-costing was constituted in collecting the direct costs. The direct health system 
costs included recurrent costs of administering a Doppler namely consumables 
during patient assessment and staff costs. There was no drug costs included since the 
radiology department is not a drug administering department. Most overhead costs 
are not affected in case of introduction of the Umbiflow Doppler machine into the 
primary health care since the existing maternity rooms will be used for the 
examinations and their maintenance is already included on the clinic budgets. 
Despite the electricity bill for the clinics’ likely increase in the instance of full 
implementation of the Umbiflow Doppler machine or the Complex fixed ultrasound 
machine at clinic level, it was impossible to determine the voltage used by the 
machines since these are lumped onto the whole clinic or hospital electricity bill. 
This resulted in the exclusion of the electricity costs in the calculations.  
 
3.3.2.2 Capital costs  
Capital costs and useful life years were obtained from the facilities procurement 
departments. The original costs of the products were provided and these were 
converted to 2013 prices. Capital costs were discounted and annualised at 3% which 
is a standard foe World Health Organisation whilst sensitivity analysis was done at 
0% and at 5% annually in order to give room for referencing and comparison 
(Drummond 2005, World Health Organisation, 2005).  Equipment and furniture was 
apportioned depending on time the capital and the number of patients was used on 
Doppler related activities vis-a-vis other diagnostic services offered by the same 
machine. The Umbiflow programme is viewed to be a scaling up programme with an 
assumption that the existing buildings will be used in implementing the project; 
therefore buildings were excluded from cost calculations.   
 
Training costs for the staff administering were included. These were costs incurred 
for training the nurses in using Doppler machines at the primary health care level. 
The useful years for training were 30 years (Wondering, Reinhold & Black, 2005). 
The same discounts rates as for capital were used given that training is considered a 





3.3.2.3 Personnel costs  
In order to ascertain the personnel costs interviews with Nurses, sonographers and 
personnel involved in the pilot project were conducted in which their government 
salary grades and the actual amounts were provided.  These were confirmed by the 
DOH from the WCDOH. Based on the time spent by the different staff administering 
Doppler at the primary health care level, the proportion of their salary was allocated 
to human resources cost of conducting a Doppler to obtain a personnel cost per 
month.  The Umbiflow computer captured every Doppler administered onto an 
online server, capturing the actual time spent per patient. However, out of the 139 
cohort, only 131 time records were found in the time sheet. The average time per 
patient for administering a Doppler on an Umbiflow machine was 4.4 minutes, using 
the 131 cohort.  However, at the tertiary and secondary hospitals, the online 
capturing of each activity was not available therefore an average of 5 minutes per 
Doppler was used. Information was obtained from key staff at the hospitals through 
an interview schedule, and the data captured into excel. Their responses could not be 
validated through a time and motion study, and hence may have over or under 
estimated the portion of their time applied to Doppler administering .The limitation 
of this strategy is the difference in patients’ weight, fetus gestation age amongst 
others which determines the time taken per patient. Therefore, stamping an average 
may not be the most accurate option.  
 
3.4 Results 
3.4.1 Patient Costs Results  
 Demography 
The patients interviewed were 41 with an average age of 26 years; the youngest 18 
and oldest 38 years. 34.2% were married, 19.5 lived with their partners whilst 46.3% 
were single and resided mostly with their parents.  78.1% formed the informal 
employment/unemployed group. 21.9 % were employed but mostly as domestic 
workers. In terms of education level, 17% (7 people) attained primary education 




The current antenatal procedure is that pregnant women with observed low SF are 
referred to the secondary institution for ultrasound test. In cases where the fetus was 
not in danger, the women were sent back to the clinic otherwise they are retained in 
the hospital. In this study, cases that were referred back to the primary health care 
were called ‘avoidable visits’ while the cases retained in the tertiary were called 
‘unavoidable cases’. Out of the 41 women interviewed, 31.7% (13) were ‘avoidable 
cases’; 61% (25) were ‘unavoidable cases’ and 7.3% (3) couldn’t go for their referral 
appointment because of financial constraints. 
 
Costs  
Although, all the patients had travel time to the primary health care but not all had 
travel cost and refreshments. Only 58.5% had travel expenses to the PHC with an 
average transport cost of R28.45. The average time of 0.8hrs was spent by all 
participants to the primary health care facilities. Table 8 reflects the return cost for 
travel expenses as mentioned by the participants. The opportunity cost was 





Table 8: Costs incurred by Patients whilst visiting the Primary Health Care 
Centre 
 
Source: calculated by authors 
 
Table 9 below contains the average breakdown of the patient costs by those who 
went for the Doppler referral appointment in the secondary hospital. As expected, the 
patients experienced higher direct and indirect costs for referral experience as they do 
need to travel far and also wait for treatment much longer.  The average travel cost 
for the patients and those that accompanied them was R38.25 and R50.20 
respectively while the average travel time for the patients alone was 1hr 41 minutes, 
translating into R16.21. The average waiting time in the hospital was over 5 hours in 
all cases. This indicates the increase in financial burden on patients who need not go 
for Doppler referral. 
 




Table 10 contains the total costs (sum of direct and indirect costs) represented as the 
average costs per patient visit for Doppler screening. As can be observed, the average 
cost is higher for tertiary visit for Doppler (R194.77) compared to R73.62 for a visit 
to the primary health care. The referral cost was further divided into avoidable and 
unavoidable visits for Doppler screening and this indicated that average cost per 
avoidable Doppler visit was higher compared to the unavoidable visit. 
Patients Caregiver Patients Caregiver




0 R12.50     
(2)
0.80hrs                  
(41 ) R 7.71
Patients





All visits R38.25 (33)









Avoidable visits R47.41 (11)
R67              
(2)
R24.63 (8)
R25.67         
(3)




Unavoidable visits R33.68 (22)




R27.44            
(9)






Direct cost Indirect cost/opportunity cost





Table 10: Patient Perspective costing summary 
 
 
The prospective total patient cost for all the 139 cohort was 9108.67 rands in the 
PHC and 19846.42 rands in the secondary hospital. The cost indicated that primary 
health care visit is far cheaper than for a secondary level visit.  
 
3.4.2 Health Systems Costs Results  
The model included personnel, consumables, and capital and equipment costs. At the 
primary level only professional based nurses work there whilst the secondary and 
tertiary hospitals have sonographers for the ultrasound Doppler administering 
rendering the costs higher for higher level institutions. The nurses on the Umbiflow 
project were not only stationed in the maternity unit. They were moved around to 
perform services in accordance to clinic regulations, resulting in new nurses having 
to be trained mid-project. The primary health care institutions have lower patient 
volumes in comparison to the higher levels i.e. an average of 15 patients for Doppler.  
 
However, the Karl Bremmer which is a referral district hospital had an average of 
185 patients per month, most of the patients coming from several community health 
centers and Clinics. It had 2 sonographers employed to administer Doppler and other 
radiology activities. Tygerberg had an average of 445 Doppler patients per month 
with 1 sonographer who was highly qualified in comparison to the other levels, 
thereby rendering her unit cost more. These numbers affected the costs of 
consumables used at the relevant institutions.    
 
Furthermore in terms of capital costs, Karl Bremmer had 2 ultrasound machines, 
with the Mindray being a new acquisition (2013 cost of R297 000) which costs 7 
times more than the Toshiba acquire in 2012 (R41 750). The Mindray DC6 is a high 
powered Doppler ultrasound machine with colour imaging.  The Soner Acer at 
Tygerberg cost R135 000 in 2012. Unlike the Umbiflow Doppler machine, the Xario, 
Mindray and Soner Acer Doppler ultrasound machines are more expensive and not 
portable. Though the Xario is movable within the hospital it is not easily portable in 
comparison to the Umbiflow.  In terms of bringing Doppler portable ultra-sounding 
to the primary level, the Umbiflow machine proves more versatile and less costly 
especially if when used for outreach clinic programmes. The Umbiflow machine 
costs ZAR 20,000. The specialised beds (Metron and Sonar couch)  used at Karl 








Transport expenses for 
monitoring  and 
referral
44.45 88.45 114.41 79.11
Time taken for return
trip
7.71 16.21 21.66 13.31
Waiting time 8.96 51.83 52.15 51.83
Money spent on food
and refreshments
12.5 38.28 50.3 54.58




examination bed at the PHC level. The same applied to the specialised chair at the 
secondary level hospital (Salli chair) whose purchase price was R6000.  
 
Having adjusted for inflation and annualised and discounted the costs at the 3%, the 
average unit cost per patient at the PHC level was estimated to be R49.62, at the 
secondary level R36.27 and at the tertiary level R18.26. The low unit cost estimates 
at the secondary and tertiary institutions were mostly affected by the extremely high 
number of referral patients attended to at Tygerberg in comparison to Karl Bremmer 
and Kraaifontein/Durbanville PHCs i.e. economies of scale. However, the total costs 
are extremely higher at secondary and tertiary hospitals, See Table 11. Adding the 
provider and patient monthly total cost, the societal costs to the PHC and secondary 
hospital amounts to 9 830.95 rands and 26 556.20 rands i.e. for secondary hospitals 
its approximately 3 times more than the PHC.  
 
Table 11: Average unit costs per patient for Doppler administering (3% 




*Average monthly Doppler patient of Kraaifontein and Durbanville calculated using 
131 cohorts 
 
3.4.2.1 Sensitivity analysis 
The sensitivity analysis is used to test the changes that may occur due to changes in 
the basic assumptions used to generate the initial results. Sensitivity analysis was 
conducted (using a baseline of 3%)  at 0% discount rate and 5% on the capital costs 
including training to check the robustness of the health systems costs. In all cases the 
costs proved to be robust. Assuming a 100% increase in Doppler’s needed for the 
women attending all levels of hospitals, the average health system costs will decrease 
drastically as shown in Table 14 below: 
Total costs Cost profile Total costs Cost profile Total costs Cost profile
Recurrent costs
Personnel 224.25                   31% 4 598.72       68.54% 6 412.02      79%
Consumables 140.27                   19% 1 422.54       21% 727.20         9%
Total recurrent costs 364.52                  50% 6 021.26      90% 7 139.22     88%
Capital costs
Furniture and Equipment  298.39 41% 580.78 8.66% 881.90 11%
Training 59.36 8% 107.74 2% 107.74 1%
Total capital costs 357.76 50% 688.52 10.26% 989.64 12%
Total monthly cost 722.28                   100% 6 709.78       100.00% 8 128.85      100%
Average unit cost per patient                     49.62            36.27           18.26 
Average monthly doppler patients per 
facility 15 185 445





Table 14: Sensitivity analysis on Average unit costs per patient for Doppler 
administering (ZAR in 2013 Value) 
 
 
3.5 Discussion and conclusion 
This study explored the cost of the introduction of the personal computer (PC)-based, 
continuous-wave Doppler machine (the Umbiflow® machine) in to the primary 
health care facilities for routine antenatal screening. The use of personal computer 
(PC)-based, continuous-wave Doppler machine has been shown to improve the 
management of pregnancies with fetal growth restriction (Odendaal & Theron 2008)  
and therefore, the machine can be considered effective. Our study results show that 
screening with Umbiflow will improve the management of pregnant women in PHC 
by reducing the cost burden of avoidable referral and lowering the burden on 
secondary level health system, and reducing the ANC default rates.  
 
A study by Abrahams et al, 2001 on the health seeking behavior of pregnant women 
in Cape Town showed that antenatal care attendance was influenced by transport cost 
among other barriers (Abrahams et al., 2001).  National MNCH mortality audit data 
showed that the majority of child and maternal mortality deaths were linked to 
avoidable factors such as poor use of health care facilities by patients and transport 
(Chopra et al., 2009). It was therefore not surprising that some pregnant women did 
not attend their referral appointment due to financial constraints and therefore lost to 
follow up.  Therefore, the DOH should consider introducing the Umbiflow Doppler 
in the PHC to avoid referrals.   
 
The secondary hospital-based Doppler strategy proved to be more costly than the 
clinic based Doppler strategy to successfully screen and retain a patient. This was 
due to extra resources required when operating a high powered Doppler machine 
specifically the sonographers. The World Health Organisation provides guidelines of 
training sonographers and general practitioners (Kurjak & Breyer, 1986). Kongnyuy 
et al., (2007) noted the importance of not only training doctors to use ultrasound in 










BASELINE VALUE 49.62 36.27 18.26
3% Discount rate on 
training only
47.89 35.81 17.85
3% Discount rate on 
capital only 48.21 36.07 18.17
Discount rate 0% (both 
capital and training) 33.74 35.61 17.77
Discount rate 5% (both 
capital and training) 37.21 36.76 18.63






from sonographers, to nursing staff has been noted as an option and this study used 
nurses in operating the Umbiflow thereby reducing operational costs. Ultimately the 
Umbiflow machine proved less costly more so if placed in a PHC.  
 
Limitations 
While considerable efforts were taken to make this study as accurate and relevant as 
possible, certain limitations arose which impacted the methodology used and how the 
results from the study can be interpreted and compared. A literature search for 
similar cost studies yielded no study. A systematic review by Harris and Marks 
(2009) revealed that there are not many costing studies dealing with the introduction 
of compact ultrasound in low resource settings (Harris & Marks, 2009). To our 
knowledge, this is the first detailed costing study of an antenatal technology 
intervention programme in South Africa context, and though a pilot study, it 
provided strong insights into possibilities of benefits of introducing a reasonable 
cheaper technology in low resource setting that could improve antenatal outcomes.   
 
The limitations also include the small sample size and the inelegant CEA study 
design. Given the fact that the evidence in this study is from a pilot study with 
limited population study group which also lacks a proper comparison group, a full 
economic evaluation of antenatal procedure as well as the introduction of the 
personal computer (PC)-based, continuous-wave Doppler machine (the Umbiflow® 
machine in the primary health care setting should be undertaken to provide a full 
picture of health benefits as well as costs.  
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MATERNAL HEALTH:  COST ANALYSIS OF INTRODUCING THE UMBIFLOW 
VELOCITY DOPPLER SYSTEM AT PRIMARY HEALTH LEVEL. A PILOT STUDY 
CONDUCTED AT KRAAIFONTEIN COMMUNITY HEALTH CENTRE AND 
DURBANVILLE DAY CLINIC 
Author: Plaxcedes Chiwire, University of Cape Town, January 2015. 
Introduction 
The study focus was on introduction of technologies that help in diagnosing 
fetus intrauterine growth retardation (IUGR) due to placental insufficiency i.e. 
the placenta’s inability to provide sufficient blood flow for the fetus to continue 
growing relative to the standard growth curve which may result in death of the 
fetus if no treatment measures are taken i.e. perinatal mortality (Calhoun Rice, 
2012). Perinatal mortality (PNMR) accounts for deaths during the period 
before the child is born (Stillbirths) and the first week of birth. It is calculated 
as the number of perinatal deaths per 1000 total births. (World Health 
Organisation, 2013) South Africa’s definition of perinatal mortality differed 
from that of World Health organisation before 2005.  
Improvement of maternal health and reduction of child mortality form Goal 4 
and 5 of the Millennium Development Goals (MDGs) advocated by signatories to 
the United Nations in 2000, South Africa included4. To achieve these goals it is 
critical that the mother and the fetus obtain medical monitoring during the 40-
42 weeks pregnancy period to avoid disability or death of the child or the 
mother. It is during this period that a fetus may fail to develop or suffers slow 
growth as a result of several clinical factors and maternal lifestyle habits5. In 
case of death occurring during that period, it is recorded with the hope that 
answers as to the cause may be obtained.  
4
 World Health Organisation, (2014). WHO _ Millennium Development Goals 4 and 5. Available at: 
http://www.who.int/pmnch/about/about_mdgs/en/index.html  [Accessed on 15 January 2014] 
5
Mook-Kanamori, D. et al., (2010). Risk factors and outcomes associated with first-trimester. The 




Worldwide, perinatal mortality is assumed to reach 3.3 million per annum, with 
6 out of 10 being stillbirths6. The developing countries account for 90% of 
worldwide perinatal mortality rate (PNMR) statistics7 . According to statistics 
from World Health Organisation, South Africa has a maternal mortality ratio of 
310 deaths per 100 000 lives births. The infant (under-1) mortality rate in 2010 
was 41 deaths per 1 000 live births, while the under-5 mortality rate was 57 per 
1 000 live births8. A South African report, Saving Babies 2010-2011, reports 
32,178 still births in a 2 year period of January 2010 to December 2011 within 
the 94% of the total hospitals who provide data to a Perinatal Problem 




The national departments of health to require that all expecting mothers be 
monitored during the 9 month period, the full duration of conception to child 
birth. In 2008/09 the National average PNMR 31.4/1000, with the Western 
Cape Province having the lowest (26.3/1000) and Free State the highest of 
37.9/100010. In 2011, South Africa was reported to have 61 stillbirths per day 
and was ranked 176 out of 193 in terms of stillbirths11. The table below gives a 
summary of births and deaths per level of care in South Africa during the years 
2010-2011  
                                                          
6 World Health Organisation, (2006). Neonatal and Perinatal Mortality: country, regional and global 
estimates. Available at: http://whqlibdoc.who.int/publications/2006/9241563206_eng.pdf  




 South Africa Info., (2013). Health Care in South Africa. Available at: 
http://www.southafrica.info/about/health/health.htm#spend  [Accessed on 31 January 2014]. 
9
 Chopra, M. et al., (2009). Saving the lives of South Africa’s mothers, babies, and children: can the 
health system deliver? Lancet, 374(9692), pp.835–46. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/19709729  [Accessed on 1 October 2014] 
10
 Health Systems Trust, 2013. South Africa’s Perinatal Mortality Rate- Health statistics. Available 
at: http://indicators.hst.org.za/healthstats/75/data/eth  [Accessed on 1 February 2013]. 
11
 Times Live-SAPA. (15 April 2011). SA experiences 60 stillbirths a day -. Times Live. Available at 





Table 8: South African Birth and Deaths per Level of Care 2010-2012 
 
Source: Saving Babies 2010-2011 
 
 Factors attributing to perinatal death include intrauterine growth restriction, 
infections, and birth trauma, maternal disease, antepartum haemorrhage, 
intrapartum hypoxia, and spontaneous preterm labour, fetal abnormalities 
whilst 38% of the still births are unexplainable12. Maternal disease may include 
HIV/AIDs, Tuberculosis, and effects from smoking amongst others13. 
Unexplained deaths are the highest amongst all causes or perinatal and still 
births in South Africa for babies weighing below 1000g.  
 
 
The policy brief reports the findings of a study conducted in the Tygerberg 
Eastern Health District of the Metro Region of Western Cape, South Africa at two 
primary health care (PHC) facilities, one secondary level hospital, and one 
tertiary hospital namely Kraaifontein Community Health Centre (CHC), 
Durbanville Day Clinic, Karl Bremmer District Hospital, and Tygerberg Hospital 
respectively. The hospitals are all public institutions funded by the Western 
Cape Department of Health (WCDOH), one of South Africa’s nine provinces. The 
study was funded by the Medical Research Council and the Council for Scientific 
and Industrial Research. The aim of the research was to conduct an economic 
                                                          
12 Health Systems Trust, (2011). Saving Mothers and Babies_ Perinatal mortality. Available at: 
http://www.slideshare.net/oerafrica/saving-mothers-and-babies-perinatal-mortality  
[Accessed on 14 February 2014]. 
13
 Health Systems Trust, (2013). South Africa’s Perinatal Mortality Rate- Health statistics. Available 













Total births 209096 548976 350838 99257 116399 1324566
Liveborn 207400 536883 341165 95956 111409 1292813
Survivor 207067 530229 336075 93746 108414 1275531
Early Neonatal Death 305 6257 4184 1765 2378 14889
Still Birth 1696 12093 9673 3813 4990 32265
Perinatal deaths 2001 18350 13857 5578 7368 47154
Total births 207017 544480 345277 96871 112216 1305861
Liveborn 206791 534580 338236 94478 109019 1283104
Survivor 207067 529358 334816 93024 107144 1271409
Early Neonatal Death 205 4895 2747 1110 1425 10382
Still Birth 1219 9900 7041 2749 3197 24106






impact in the introduction of an Umbiflow Doppler machine in the primary 
health care with the major goal being to reduce the number of perinatal deaths 
in the public health system.   
 
Research Objective  
The study determined the cost of introducing a continuous-wave Doppler 
analyser (Umbiflow Intervention) at primary antenatal care facilities; average 
cost per patient to the secondary level hospital from the patient’s perspective 
and the average cost per patient referral for a Doppler to the secondary level 
hospital from the health system perspective 
 
Methods  
A cross- sectional analytical study was conducted from the societal perspective. 
The Economic Impact study will be carried out on the already approved sample 
size of 139 patients stemming from the Umbiflow Clinical study. The inclusion 
criteria for patient participation is poor SF growth and late bookers >28 weeks 
attending Kraaifontein Community Health Care Centre and Durbanville Clinic 
for antenatal services.  
 
The data collection instruments comprised of two questionnaires. The first 
questionnaire was for patient costing and the second for facility costing. 
Physical observation was used to calculate the staff time per general patient 
(one who does not need a Doppler) at the primary health level. The extra staff 
time for a Doppler needing patient will be attained from the Umbiflow system 
which captures time stamps automatically and uploads the information to a 
central server. The average time needed for a Doppler was validated in the 
facility questionnaire.  
 
Findings  
 An average transport cost of ZAR 28.45. The average time of 0.8hrs was 
spent by all participants to the primary health care facilities. The opportunity 
cost was calculated by multiplying the time with the proxy hourly rate of R9.63. 
 As expected, the patients experienced higher direct and indirect costs for 




time before being attended to.  The average travel cost for the patients and 
those that accompanied them was ZAR 38 and ZAR 50.20 respectively while 
the average travel time for the patients alone was 1hr 41 minutes. The 
average waiting time in the secondary hospital was over 5 hours 
 
 The prospective total patient costs for the 139 cohort was ZAR 9108.67 in 
the PHC and 19846.42 rands in the secondary hospital. 
 The PHC had lower patient volumes in comparison to the higher levels i.e. 
an average of 15 patients per month for Doppler. However, the Karl 
Bremmer which is a referral district hospital had an average of 185 patients 
per month, most of the patients coming from several CHC and Clinics. 
Tygerberg had an average of 445 Doppler patients per month 
 Having adjusted for inflation and annualised and discounted the costs at the 
3%, the average unit cost per patient at the PHC level was estimated to be 
ZAR 49.62, at the secondary level ZAR 36.27 and at the tertiary level ZAR 
18.26. The low unit cost estimates at the secondary and tertiary institutions 
were mostly affected by the extremely high number of referral patients 
attended to at Tygerberg in comparison to Karl Bremmer and 
Kraaifontein/Durbanville PHCs i.e. economies of scale. However, the total 
costs are extremely higher at secondary and tertiary hospitals 
 
Table 9 : Average unit costs per patient for Doppler administering (3% discount 
rate; ZAR in 2013 Value) 
 
 
Total costs Cost profile Total costs Cost profile Total costs Cost profile
Recurrent costs
Personnel 224.25                   31% 4 598.72       68.54% 6 412.02      79%
Consumables 140.27                   19% 1 422.54       21% 727.20         9%
Total recurrent costs 364.52                  50% 6 021.26      90% 7 139.22     88%
Capital costs
Furniture and Equipment  298.39 41% 580.78 8.66% 881.90 11%
Training 59.36 8% 107.74 2% 107.74 1%
Total capital costs 357.76 50% 688.52 10.26% 989.64 12%
Total monthly cost 722.28                   100% 6 709.78       100.00% 8 128.85      100%
Average unit cost per patient                     49.62            36.27           18.26 
Average monthly doppler patients per 
facility 15 185 445




 Assuming we cost the research protocol as per the Western Cape Department of 
Health which does not include Doppler testing on 1st bookers the cost for PHC 
would be very high i.e. 240 rands average unit cost per patient due to the low 
number in follow up patients referred for Doppler testing per month  
 Assuming a 100% increase in Doppler’s needed for the women attending all 
levels of hospitals, the average health system costs will decrease drastically 
as shown 
 
The Implication of the Findings on Policy.  
 Patients who are from a poor background are incurring catastrophic costs 
in seeking Antenatal Care especially during referrals to secondary care if 
found to need extra monitoring. Some even abscond from referral visits.   
 The waiting times at both PHC and secondary care for ANC and Doppler 
ultrasound are long. This is due to the high numbers of patients in the PHC 
and Secondary Hospitals. Interventions to reduce waiting time need to be 
put in place.  
 There is a possible reduction of referrals with the introduction of the 
Umbiflow Doppler ultrasound Machine at the PHC level. 
 Costs carried by the health system for avoidable referrals are huge and can 
be reduced by introducing an intervention at the PHC level. This means 
reviewing the Basic Antenatal Care Handbook which stipulates the protocol 
for ANC in the public Hospitals 
 
Recommendation  
 It is recommended that the Umbiflow ultrasound machine be introduced on a 
wider scale in PHC as a form of reducing referrals for Doppler to Secondary 
and tertiary care hospitals. Training of nursing staff on a wider scale should 
also be implemented if Umbiflow ultra sounding is to be introduced in the 
PHC for the same reason.  
 Alternatively, the department of health could bring the higher powered 
ultrasound machines into the PHC for Doppler ultra-sounding but this would 






South Africa is experiencing a perinatal mortality crisis, which is testing its 
health system. In order to curtail these problem new cheaper technologies can 
be introduced at primary health care level, the first port of ANC. In so doing, the 
study findings show how cost effective it is to adopt one those technologies, i.e. 
the portable, easy-to use, Umbiflow Doppler ultra-sound machine to reduce 
patient and health provider costs. It would also ensure patients do not abscond 
from referrals due to financial costs. Adopting a policy that can see wider 
implementation of the Umbiflow would be the first step to reducing the high 
rate of perinatal deaths and ensure favourable fetal outcomes.    
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will be provided there). You should pay very close attention to the 
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formulation of the Research Highlights for your article. Make sure that they are 
clear, concise and capture the reader's attention. If your research highlights do 
not meet these criteria we may need to return your article to you leading to a 






Up to 8 keywords are entered separately into the online editorial system during 
submission, and should accurately reflect the content of the article. Again 
abbreviations/acronyms should be used only if essential or firmly established. 
For empirical papers the country/countries/locations of the research should be 
included. The keywords will be used for indexing purposes. 
Methods 
Authors of empirical papers are expected to provide full details of the research 
methods used, including study location(s), sampling procedures, the date(s) 
when data were collected, research instruments, and techniques of data 
analysis. Specific guidance on the reporting of qualitative studies are provided 
here. 
Footnotes 




• Make sure you use uniform lettering and sizing of your original artwork. 
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, 
Courier. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Indicate per figure if it is a single, 1.5 or 2-column fitting image. 
• For Word submissions only, you may still provide figures and their captions, 
and tables within a single file at the revision stage. 
• Please note that individual figure files larger than 10 MB must be provided in 
separate source files. 
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/artworkinstructions. 
You are urged to visit this site; some excerpts from the detailed information are 
given here. 
Formats 
Regardless of the application used, when your electronic artwork is finalized, 
please 'save as' or convert the images to one of the following formats (note the 
resolution requirements for line drawings, halftones, and line/halftone 
combinations given below): 
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'. 
TIFF (or JPG): Color or grayscale photographs (halftones): always use a 
minimum of 300 dpi. 
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi. 
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a 
minimum of 500 dpi is required. 
Please do not: 
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the 
resolution is too low. 
• Supply files that are too low in resolution. 
• Submit graphics that are disproportionately large for the content. 
Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), 
EPS (or PDF), or MS Office files) and with the correct resolution. If, together 




ensure, at no additional charge, that these figures will appear in color online 
(e.g., ScienceDirect and other sites) regardless of whether or not these 
illustrations are reproduced in color in the printed version. For color 
reproduction in print, you will receive information regarding the costs from 
Elsevier after receipt of your accepted article. Please indicate your preference 
for color: in print or online only. For further information on the preparation of 
electronic artwork, please see http://www.elsevier.com/artworkinstructions. 
Please note: Because of technical complications that can arise by converting 
color figures to 'gray scale' (for the printed version should you not opt for color 
in print) please submit in addition usable black and white versions of all the 
color illustrations. 
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Figure captions 
Ensure that each illustration has a caption. A caption should comprise a brief 
title (not on the figure itself) and a description of the illustration. Keep text in 
the illustrations themselves to a minimum but explain all symbols and 
abbreviations used. 
Tables 
Please submit tables as editable text and not as images. Tables can be placed 
either next to the relevant text in the article, or on separate page(s) at the end. 
Number tables consecutively in accordance with their appearance in the text 
and place any table notes below the table body. Be sparing in the use of tables 
and ensure that the data presented in them do not duplicate results described 
elsewhere in the article. Please avoid using vertical rules. 
References 
Citation in text 
Please ensure that every reference cited in the text is also present in the 
reference list (and vice versa). 
Any references cited in the abstract must be given in full at the end of the 
abstract. Unpublished results and personal communications are not 
recommended in the reference list, but may be mentioned in the text. If these 
references are included in the reference list they should follow the standard 
reference style of the journal (see below) and should include a substitution of 
the publication date with either "Unpublished results" or "Personal 
communication" Citation of a reference as "in press" implies that the item has 
been accepted for publication. 
Web references 
As a minimum, the full URL should be given and the date when the reference 
was last accessed. Any further information, if known (DOI, author names, dates, 
reference to a source publication, etc.), should also be given. Web references can 
be listed separately (e.g., after the reference list) under a different heading if 
desired, or can be included in the reference list. 
References in special issue articles, commentaries and responses to 
commentaries 
Please ensure that the words 'this issue' are added to any references in the 
reference list (and any citations in the text) to other articles which are referred 
to in the same issue. 
Reference management software 
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This journal has standard templates available in key reference management 
packages EndNote (http://www.endnote.com/support/enstyles.asp) and 
Reference Manager 
(http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing 
packages, authors only need to select the appropriate journal template when 
preparing their article and the list of references and citations to these will be 
formatted according to the journal style which is described below. 
The current Social Science & Medicine EndNote file can be directly accessed by 
clicking here. 
Reference formatting 
There are no strict requirements on reference formatting at submission. 
References can be in any style or format as long as the style is consistent. Where 
applicable, author(s) name(s), journal title/book title, chapter title/article title, 
year of publication, volume number/book chapter and the pagination must be 
present. Use of DOI is highly encouraged. The reference style used by the journal 
will be applied to the accepted article by Elsevier at the proof stage. Note that 
missing data will be highlighted at proof stage for the author to correct. If you 
do wish to format the references yourself they should be arranged according to 
the following examples: 
Reference style 
Text: Citations in the text should follow the referencing style used by the 
American Psychological Association. You are referred to the Publication Manual 
of the American Psychological Association, Sixth Edition, ISBN 978-1-4338-
0561-5, copies of which may be ordered from 
http://books.apa.org/books.cfm?id=4200067  or APA Order Dept., P.O.B. 2710, 
Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, WC3E 8LU, UK. 
List: references should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) 
in the same year must be identified by the letters 'a', 'b', 'c', etc., placed after the 
year of publication. 
Examples: 
Reference to a journal publication: 
Van der Geer, J., Hanraads, J. A. J., & Lupton, R. A. (2010). The art of writing a 
scientific article. Journal of Scientific Communications, 163, 51–59. 
Reference to a book: 
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Strunk, W., Jr., & White, E. B. (2000). The elements of style. (4th ed.). New York: 
Longman, (Chapter 4). 
Reference to a chapter in an edited book: 
Mettam, G. R., & Adams, L. B. (2009). How to prepare an electronic version of 
your article. In B. S. Jones, & R. Z. Smith (Eds.), Introduction to the electronic age 
(pp. 281–304). New York: E-Publishing Inc. 
Video data 
Elsevier accepts video material and animation sequences to support and 
enhance your scientific research. Authors who have video or animation files that 
they wish to submit with their article may do so during online submission. 
Where relevant, authors are strongly encouraged to include a video still within 
the body of the article. This can be done in the same way as a figure or table by 
referring to the video or animation content and noting in the body text where it 
should be placed. These will be used instead of standard icons and will 
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personalize the link to your video data. All submitted files should be properly 
labeled so that they directly relate to the video file's content. In order to ensure 
that your video or animation material is directly usable, please provide the files 
in one of our recommended file formats with a maximum size of 10 MB. Video 
and animation files supplied will be published online in the electronic version of 
your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. For more detailed instructions please visit our 
video instruction pages at http://www.elsevier.com/artworkinstructions. Note: 
since video and animation cannot be embedded in the print version of the 
journal, please provide text for both the electronic and the print version for the 
portions of the article that refer to this content. 
AudioSlides 
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are 
shown next to the online article on ScienceDirect. This gives authors the 
opportunity to summarize their research in their own words and to help 
readers understand what the paper is about. More information and examples 
are available at 
http://www.elsevier.com/audioslides. Authors of this journal will automatically 
receive an invitation e-mail to create an AudioSlides presentation after 
acceptance of their paper. 
Supplementary data 
Elsevier accepts electronic supplementary material to support and enhance 
your research. Supplementary files offer the author additional possibilities to 
publish supporting applications, accompanying videos describing the research, 
more detailed tables, background datasets, sound clips and more. 
Supplementary files supplied will be published online alongside the electronic 
version of your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. In order to ensure that your submitted material 
is directly usable, please provide the data in one of our recommended file 
formats. Authors should submit the material in electronic format together with 
the article and supply a concise and descriptive caption for each file. For more 
detailed instructions please visit our artwork instruction pages at 
http://www.elsevier.com/artworkinstructions. 
Submission checklist 
The following list will be useful during the final checking of an article prior to 
sending it to the journal for review. Please consult this Guide for Authors for 
further details of any item. 
Ensure that the following items are present: 
One author has been designated as the corresponding author with contact 
details: 
• E-mail address
• Full postal address
• Telephone
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked' and 'grammar-checked'
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• All references mentioned in the Reference list are cited in the text, and vice
versa
• Permission has been obtained for use of copyrighted material from other
sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on
the Web (free of charge) and in print, or to be reproduced in color on the Web
(free of charge) and in black-and-white in print
• If only color on the Web is required, black-and-white versions of the figures
are also supplied for printing purposes
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For any further information please visit our customer support site at
http://support.elsevier.com.
AFTER ACCEPTANCE
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic
documents. The DOI consists of a unique alpha-numeric character string which
is assigned to a document by the publisher upon the initial electronic
publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document, particularly 'Articles in press' because they have not yet
received their full bibliographic information. Example of a correctly given DOI
(in URL format; here an article in the journal Physics Letters B):
http://dx.doi.org/10.1016/j.physletb.2010.09.059
When you use a DOI to create links to documents on the web, the DOIs are
guaranteed never to change.
Online proof correction
Corresponding authors will receive an e-mail with a link to our online proofing
system, allowing annotation and correction of proofs online. The environment is
similar to MS Word: in addition to editing text, you can also comment on
figures/tables and answer questions from the Copy Editor.
Web-based proofing provides a faster and less error-prone process by allowing
you to directly type your corrections, eliminating the potential introduction of
errors.
If preferred, you can still choose to annotate and upload your edits on the PDF
version. All instructions for proofing will be given in the e-mail we send to
authors, including alternative methods to the online version and PDF.
We will do everything possible to get your article published quickly and
accurately. Please use this proof only for checking the typesetting, editing,
completeness and correctness of the text, tables and figures. Significant changes
to the article as accepted for publication will only be considered at this stage
with permission from the Editor.It is important to ensure that all corrections are
sent back to us in one communication. Please check carefully before replying, as
inclusion of any subsequent corrections cannot be guaranteed. Proofreading is
solely your responsibility.
Offprints
The corresponding author, at no cost, will be provided with a personalized link
providing 50 days free access to the final published version of the article on
ScienceDirect. This link can also be used for sharing via email and social
networks. For an extra charge, paper offprints can be ordered via the offprint
order form which is sent once the article is accepted for publication. Both
corresponding and co-authors may order offprints at any time via Elsevier's
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WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors 
requiring printed copies of multiple articles may use Elsevier WebShop's 'Create 
Your Own Book' service to collate multiple articles within a single cover 
(http://webshop.elsevier.com/myarticleservices/booklets). 
AUTHOR ENQUIRIES 
For inquiries relating to the submission of articles please contact the office of 
the Editors in Chief at eicssm@gmail.com 
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